Characterization	O
of	O
a	O
new	O
tissue-specific	O
transcription	B-protein
factor	I-protein
binding	O
to	O
the	O
simian	B-DNA
virus	I-DNA
40	I-DNA
enhancer	I-DNA
TC-II	I-DNA
(	I-DNA
NF-kappa	I-DNA
B	I-DNA
)	I-DNA
element	I-DNA
.	O

We	O
have	O
biochemically	O
and	O
functionally	O
characterized	O
a	O
new	O
transcription	B-protein
factor	I-protein
,	O
NP-TCII	B-protein
,	O
which	O
is	O
present	O
in	O
nuclei	O
from	O
unstimulated	B-cell_line
T	I-cell_line
and	I-cell_line
B	I-cell_line
lymphocytes	I-cell_line
but	O
is	O
not	O
found	O
in	O
nonhematopoietic	B-cell_type
cells	I-cell_type
.	O

This	O
factor	O
has	O
a	O
DNA-binding	O
specificity	O
similar	O
to	O
that	O
of	O
NF-kappa	B-protein
B	I-protein
but	O
is	O
unrelated	O
to	O
this	O
or	O
other	O
Rel	B-protein
proteins	I-protein
by	O
functional	O
and	O
biochemical	O
criteria	O
.	O

It	O
can	O
also	O
be	O
distinguished	O
from	O
other	O
previously	O
described	O
lymphocyte-specific	B-protein
DNA-binding	I-protein
proteins	I-protein
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGy	NULL
,	NULL
Nov.	NULL
1992	NULL
,	NULL
p.	NULL
5217-5227	NULL
0270-7306/92/115217-11	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1992	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

12	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Characterization	NULL
of	NULL
a	NULL
New	NULL
Tissue-Specific	NULL
Transcription	NULL
Factor	NULL
Binding	NULL
to	NULL
the	NULL
Simian	NULL
Virus	NULL
40	NULL
Enhancer	NULL
TC-II	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
Element	NULL
ANNE-LAURE	NULL
LATTION	NULL
,	NULL
'*	NULL
ENRIC	NULL
ESPEL	NULL
,	NULL
*	NULL
PATRICK	NULL
REICHENBACH	NULL
,	NULL
!	NULL

CATHERINE	NULL
FROMENTAL	NULL
,	NULL
*	NULL
PHILIPP	NULL
BUCHER	NULL
,	NULL
'	NULL
ALAIN	NULL
ISRAEL	NULL
,	NULL
*	NULL
PATRICK	NULL
BAEUERLE	NULL
,	NULL
*	NULL
NANCY	NULL
R.	NULL
RICE	NULL
,	NULL
``	NULL
anp	NULL
MARKUS	NULL
NABHOLZ	NULL
!	NULL

Swiss	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
,	NULL
155	NULL
,	NULL
ch	NULL
.	NULL

des	NULL
Boveresses	NULL
,	NULL
CH-1066	NULL
Epalinges	NULL
,	NULL
Switzerland	NULL
``	NULL
;	NULL
Faculté	NULL
de	NULL
Médecine	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Medicale	NULL
(	NULL
INSERM	NULL
)	NULL
U184	NULL
,	NULL
F-67085	NULL
Strasbourg	NULL
,	NULL
France	NULL
;	NULL
INSERM	NULL
U277	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
F-75724	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
Genzentrum	NULL
,	NULL
Klopfenspitz	NULL
,	NULL
D-8033	NULL
Martinsried	NULL
,	NULL
Germany	NULL
'	NULL
;	NULL
and	NULL
Frederick	NULL
Research	NULL
and	NULL
Development	NULL
Center	NULL
,	NULL
Frederick	NULL
,	NULL
Maryland	NULL
21701-1201	NULL
``	NULL
Received	NULL
15	NULL
May	NULL
1992/Returned	NULL
for	NULL
modification	NULL
6	NULL
July	NULL
1992/Accepted	NULL
27	NULL
August	NULL
1992	NULL
We	NULL
have	NULL
biochemically	NULL
and	NULL
functionally	NULL
characterized	NULL
a	NULL
new	NULL
transcription	NULL
factor	NULL
,	NULL
NP-TC	NULL
,	NULL
,	NULL
,	NULL
which	NULL
is	NULL
present	NULL
in	NULL
nuclei	NULL
from	NULL
unstimulated	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
but	NULL
is	NULL
not	NULL
found	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
.	NULL

This	NULL
factor	NULL
has	NULL
a	NULL
DNA-binding	NULL
specificity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
NF-sB	NULL
but	NULL
is	NULL
unrelated	NULL
to	NULL
this	NULL
or	NULL
other	NULL
Rel	NULL
proteins	NULL
by	NULL
functional	NULL
and	NULL
biochemical	NULL
criteria	NULL
.	NULL

It	NULL
can	NULL
also	NULL
be	NULL
distinguished	NULL
from	NULL
other	NULL
previously	NULL
described	NULL
lymphocyte-specific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

The	NULL
TC-II	NULL
motif	NULL
in	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
enhancer	NULL
[	NULL
5'-	NULL
(	NULL
246	NULL
)	NULL
TGGAAAGTCCCCA	NULL
(	NULL
234	NULL
)	NULL
-3	NULL
'	NULL
]	NULL
mediates	NULL
a	NULL
strong	NULL
transcriptional	NULL
response	NULL
to	NULL
stimulation	NULL
by	NULL
interleukin	NULL
1	NULL
(	NULL
IL-1	NULL
)	NULL
.	NULL

Previous	NULL
work	NULL
indicates	NULL
that	NULL
this	NULL
response	NULL
is	NULL
due	NULL
to	NULL
activation	NULL
of	NULL
NF-KB	NULL
(	NULL
10	NULL
,	NULL
33	NULL
,	NULL
43	NULL
)	NULL
,	NULL
which	NULL
specifically	NULL
binds	NULL
to	NULL
the	NULL
TC-II	NULL
sequence	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
in	NULL
an	NULL
immature	NULL
T-cell	NULL
line	NULL
,	NULL
PC60	NULL
(	NULL
7	NULL
)	NULL
,	NULL
IL-1	NULL
induces	NULL
the	NULL
appearance	NULL
of	NULL
maximal	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
less	NULL
than	NULL
20	NULL
min	NULL
and	NULL
induces	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
B-globin	NULL
reporter	NULL
gene	NULL
whose	NULL
promoter	NULL
contains	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
TC-II	NULL
enhanson	NULL
.	NULL

Although	NULL
nuclei	NULL
from	NULL
nonstimulated	NULL
PC6O	NULL
cells	NULL
contain	NULL
no	NULL
detectable	NULL
NF-kB	NULL
,	NULL
the	NULL
TC-II	NULL
motif	NULL
also	NULL
acts	NULL
as	NULL
a	NULL
constitutive	NULL
enhanson	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
10	NULL
)	NULL
,	NULL
the	NULL
TC-II	NULL
sequence	NULL
not	NULL
only	NULL
binds	NULL
NF-	NULL
«	NULL
B	NULL
but	NULL
also	NULL
forms	NULL
specific	NULL
complexes	NULL
with	NULL
other	NULL
proteins	NULL
that	NULL
are	NULL
constitutively	NULL
active	NULL
in	NULL
PC6O0	NULL
cells	NULL
but	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
a	NULL
pre-B-cell	NULL
line	NULL
,	NULL
70Z/3	NULL
.	NULL

In	NULL
this	NULL
article	NULL
,	NULL
we	NULL
describe	NULL
a	NULL
more	NULL
detailed	NULL
characterization	NULL
of	NULL
this	NULL
TC-II-specific	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
(	NULL
here	NULL
called	NULL
NP-TC	NULL
;	NULL
,	NULL
;	NULL
)	NULL
.	NULL

We	NULL
show	NULL
that	NULL
NP-TC	NULL
,	NULL
,	NULL
binding	NULL
activity	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
but	NULL
not	NULL
in	NULL
nonhemopoietic	NULL
cell	NULL
types	NULL
,	NULL
which	NULL
suggests	NULL
a	NULL
role	NULL
for	NULL
NP-TC	NULL
;	NULL
,	NULL
in	NULL
lymphocyte	NULL
differentiation	NULL
.	NULL

We	NULL
present	NULL
evidence	NULL
that	NULL
the	NULL
constitutive	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
TC-II	NULL
motif	NULL
is	NULL
indeed	NULL
due	NULL
to	NULL
NP-TC	NULL
;	NULL
.	NULL

The	NULL
biochemical	NULL
and	NULL
functional	NULL
properties	NULL
of	NULL
NP-TCy	NULL
,	NULL
rule	NULL
out	NULL
a	NULL
close	NULL
relationship	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
other	NULL
proteins	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
and	NULL
show	NULL
that	NULL
NP-TC	NULL
;	NULL
;	NULL
is	NULL
different	NULL
from	NULL
other	NULL
lymphocyte-specific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
and	NULL
probes	NULL
.	NULL

TC-II	NULL
probe	NULL
.	NULL

The	NULL
TC-II-containing	NULL
,	NULL
EcoRI-HindIII	NULL
73-bp	NULL
fragment	NULL
of	NULL
pSPT-TCII	NULL
was	NULL
end	NULL
labelled	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

pG1	NULL
plasmids	NULL
.	NULL

pG1	NULL
contains	NULL
the	NULL
rabbit	NULL
B-globin	NULL
gene	NULL
from	NULL
positions	NULL
-109	NULL
to	NULL
+1650	NULL
inserted	NULL
into	NULL
pBR322	NULL
.	NULL

pG1.TC-30	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

5217	NULL
contains	NULL
an	NULL
inverted	NULL
head-to-tail	NULL
tetramer	NULL
of	NULL
the	NULL
SV40	NULL
TC-II	NULL
motif	NULL
(	NULL
bp	NULL
233	NULL
to	NULL
247	NULL
[	NULL
49	NULL
]	NULL
)	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
.	NULL

pGI.TC-33	NULL
to	NULL
-TC-46	NULL
differ	NULL
from	NULL
pG1.TC-30	NULL
by	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
TC-II	NULL
motif	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Plasmids	NULL
were	NULL
purified	NULL
by	NULL
polyethylene	NULL
glycol	NULL
precipitation	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
TC-II	NULL
tetram-ers	NULL
were	NULL
resequenced	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
tet-rameric	NULL
fragments	NULL
were	NULL
excised	NULL
and	NULL
purified	NULL
on	NULL
a	NULL
4	NULL
%	NULL
low-melting-point	NULL
agarose	NULL
(	NULL
Nusieve	NULL
;	NULL
FMC	NULL
,	NULL
Rockland	NULL
,	NULL
Maine	NULL
)	NULL
gel	NULL
.	NULL

pGBAcBGID	NULL
plasmid	NULL
contains	NULL
a	NULL
version	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
carrying	NULL
a	NULL
40-bp	NULL
deletion	NULL
in	NULL
the	NULL
second	NULL
exon	NULL
and	NULL
is	NULL
transcribed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
constitutive	NULL
chicken	NULL
B-actin	NULL
promoter	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
cytokine	NULL
induction	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
exponentially	NULL
to	NULL
4	NULL
x	NULL
10°	NULL
to	NULL
8	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

An	NULL
aliquot	NULL
was	NULL
treated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
human	NULL
recombinant	NULL
IL-1fB	NULL
(	NULL
1	NULL
ng/ml	NULL
;	NULL
a	NULL
gift	NULL
of	NULL
Glaxo	NULL
)	NULL
or	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
(	NULL
10+	NULL
U/ml	NULL
;	NULL
a	NULL
gift	NULL
of	NULL
W.	NULL
Fiers	NULL
,	NULL
Gent	NULL
University	NULL
)	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
near	NULL
confluency	NULL
and	NULL
induced	NULL
on	NULL
the	NULL
plate	NULL
.	NULL

Thymocytes	NULL
and	NULL
splenic	NULL
lymphocytes	NULL
were	NULL
prepared	NULL
by	NULL
gentle	NULL
homogenization	NULL
of	NULL
the	NULL
tissues	NULL
.	NULL

Nylon	NULL
wool	NULL
columns	NULL
were	NULL
used	NULL
to	NULL
separate	NULL
Ficoll-purified	NULL
spleen	NULL
cells	NULL
into	NULL
a	NULL
nonadherent	NULL
(	NULL
-90	NULL
%	NULL
T-cell	NULL
)	NULL
and	NULL
an	NULL
adherent	NULL
(	NULL
>	NULL
90	NULL
%	NULL
B-cell	NULL
)	NULL
fraction	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
gel	NULL
retardation	NULL
assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
at	NULL
4°C	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
.	NULL

4-Amidinophenylmethylsulfony	NULL
!	NULL

fluoride	NULL
(	NULL
50	NULL
pg/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
buffer	NULL
A.	NULL
Adherent	NULL
cells	NULL
were	NULL
lysed	NULL
directly	NULL
on	NULL
the	NULL
plate	NULL
.	NULL

Extracts	NULL
were	NULL
aliquoted	NULL
and	NULL
stored	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

For	NULL
proteolysis	NULL
experiments	NULL
,	NULL
nuclear	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
trypsin	NULL
(	NULL
50	NULL
ng/4	NULL
to	NULL
15	NULL
pug	NULL
of	NULL
total	NULL
protein	NULL
;	NULL
Boehringer	NULL
Mann-heim	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
addition	NULL
of	NULL
500	NULL
ng	NULL
of	NULL
aprotinin	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

IxB	NULL
and	NULL
antibodies	NULL
.	NULL

IxBa	NULL
was	NULL
purified	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
the	NULL
human	NULL
5218	NULL
LATTION	NULL
ET	NULL
AL	NULL
.	NULL

p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
antiserum	NULL
2	NULL
against	NULL
amino	NULL
acids	NULL
19	NULL
to	NULL
969	NULL
of	NULL
p50	NULL
)	NULL
have	NULL
been	NULL
described	NULL
by	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
those	NULL
against	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
chicken	NULL
v-re/	NULL
protein	NULL
expressed	NULL
in	NULL
bacteria	NULL
(	NULL
antisera	NULL
1	NULL
and	NULL
2	NULL
against	NULL
amino	NULL
acids	NULL
148	NULL
to	NULL
316	NULL
and	NULL
346	NULL
to	NULL
438	NULL
of	NULL
p59	NULL
)	NULL
have	NULL
been	NULL
described	NULL
by	NULL
Simek	NULL
et	NULL
al	NULL
.	NULL

(	NULL
45	NULL
)	NULL
.	NULL

Gel	NULL
filtration	NULL
chromatography	NULL
.	NULL

Nuclear	NULL
extract	NULL
of	NULL
ELA	NULL
cells	NULL
(	NULL
3.6	NULL
mg	NULL
of	NULL
total	NULL
proteins	NULL
)	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
calibrated	NULL
Superose	NULL
12	NULL
column	NULL
(	NULL
Pharmacia	NULL
)	NULL
equilibrated	NULL
with	NULL
nuclear	NULL
extraction	NULL
buffer	NULL
(	NULL
buffer	NULL
C	NULL
)	NULL
containing	NULL
0.4	NULL
M	NULL
NaCl	NULL
.	NULL

During	NULL
elution	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
,	NULL
300-4l	NULL
fractions	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
a	NULL
1.5-pl	NULL
aliquot	NULL
of	NULL
each	NULL
fraction	NULL
was	NULL
used	NULL
to	NULL
test	NULL
TC-II	NULL
binding	NULL
activity	NULL
.	NULL

Heparin	NULL
chromatography	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
PC60	NULL
cells	NULL
induced	NULL
by	NULL
IL-1	NULL
(	NULL
2	NULL
mg	NULL
of	NULL
total	NULL
protein	NULL
)	NULL
were	NULL
passed	NULL
over	NULL
a	NULL
heparin-Sepharose	NULL
column	NULL
(	NULL
1	NULL
ml	NULL
of	NULL
wet	NULL
resin	NULL
;	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
column	NULL
was	NULL
eluted	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
0.2	NULL
ml/min	NULL
with	NULL
a	NULL
step	NULL
gradient	NULL
(	NULL
2	NULL
mIl/50	NULL
mM	NULL
change	NULL
in	NULL
KCI	NULL
concentration	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-NV	NULL
'	NULL
-2-ethanesulfonic	NULL
acid	NULL
)	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
B-mercaptoethanol	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
0.2	NULL
mM	NULL
EDTA	NULL
.	NULL

Fractions	NULL
(	NULL
0.3	NULL
ml	NULL
)	NULL
were	NULL
assayed	NULL
for	NULL
NP-TC	NULL
;	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Band	NULL
shifts	NULL
,	NULL
footprints	NULL
,	NULL
and	NULL
DNA	NULL
methylation	NULL
protection	NULL
.	NULL

Binding	NULL
reactions	NULL
and	NULL
electrophoresis	NULL
conditions	NULL
for	NULL
gel	NULL
retardation	NULL
assays	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
.	NULL

About	NULL
300	NULL
pg	NULL
(	NULL
=	NULL
6	NULL
fmol	NULL
)	NULL
of	NULL
labeled	NULL
TC-II	NULL
fragment	NULL
from	NULL
pSPT-TCII	NULL
was	NULL
added	NULL
in	NULL
all	NULL
reaction	NULL
mixtures	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
250	NULL
to	NULL
300	NULL
fmol	NULL
of	NULL
unlabeled	NULL
DNA	NULL
was	NULL
in-cluded	NULL
.	NULL

Footprints	NULL
were	NULL
obtained	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
,	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
.	NULL

Two	NULL
or	NULL
4	NULL
pl	NULL
of	NULL
heparin-fractionated	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
6	NULL
ng	NULL
of	NULL
labelled	NULL
SV40	NULL
Haelll-Ncol	NULL
fragment	NULL
(	NULL
nucleotides	NULL
[	NULL
nt	NULL
]	NULL
331	NULL
to	NULL
40	NULL
)	NULL
in	NULL
12	NULL
ul	NULL
containing	NULL
4	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
mM	NULL
B-mercaptoethanol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

After	NULL
30	NULL
min	NULL
,	NULL
1	NULL
pl	NULL
(	NULL
0.2	NULL
U	NULL
)	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
Pharmacia	NULL
)	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-10	NULL
mM	NULL
CaCl	NULL
,	NULL
-10	NULL
mM	NULL
MgCIl	NULL
;	NULL
-50	NULL
%	NULL
glycerol	NULL
was	NULL
added	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
after	NULL
1	NULL
min	NULL
.	NULL

Competitions	NULL
included	NULL
a	NULL
22	NULL
M	NULL
excess	NULL
of	NULL
TC-II	NULL
motif	NULL
excised	NULL
from	NULL
pG1.TC-30	NULL
.	NULL

Transfections	NULL
.	NULL

PC	NULL
60.21.14.4	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
44	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
mixtures	NULL
of	NULL
a	NULL
pG1	NULL
plasmid	NULL
and	NULL
the	NULL
reference	NULL
plasmid	NULL
pGBAcBGID	NULL
,	NULL
treated	NULL
with	NULL
IL-1	NULL
,	NULL
and	NULL
processed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
activities	NULL
of	NULL
different	NULL
plasmids	NULL
were	NULL
compared	NULL
by	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction-based	NULL
assay	NULL
developed	NULL
by	NULL
Sperisen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
46	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
RNA	NULL
from	NULL
transfected	NULL
cells	NULL
was	NULL
reverse	NULL
tran-scribed	NULL
,	NULL
and	NULL
the	NULL
cDNA	NULL
was	NULL
amplified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
«	NULL
-	NULL
``	NULL
°P	NULL
]	NULL
dATP	NULL
with	NULL
primers	NULL
spanning	NULL
the	NULL
first	NULL
intron	NULL
of	NULL
the	NULL
B-globin	NULL
reporter	NULL
gene	NULL
as	NULL
well	NULL
as	NULL
the	NULL
deletion	NULL
in	NULL
the	NULL
pGBAcBGID	NULL
reference	NULL
plasmid	NULL
.	NULL

Polymerase	NULL
chain	NULL
reaction	NULL
products	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
sequencing	NULL
gel	NULL
,	NULL
and	NULL
signals	NULL
due	NULL
to	NULL
pGl	NULL
and	NULL
pGBAcBG1D	NULL
mRNA	NULL
were	NULL
quantified	NULL
by	NULL
densitometric	NULL
analysis	NULL
.	NULL

Their	NULL
ratio	NULL
is	NULL
a	NULL
linear	NULL
function	NULL
of	NULL
the	NULL
ratio	NULL
of	NULL
transfecting	NULL
plasmid	NULL
DNAs	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
when	NULL
cells	NULL
are	NULL
transfected	NULL
with	NULL
the	NULL
same	NULL
ratio	NULL
of	NULL
different	NULL
pGI.TC	NULL
plasmids	NULL
and	NULL
pGBAcBG1D	NULL
,	NULL
the	NULL
signal	NULL
ratios	NULL
obtained	NULL
are	NULL
proportional	NULL
to	NULL
the	NULL
promoter	NULL
strength	NULL
of	NULL
the	NULL
pG1.TC	NULL
plasmids	NULL
.	NULL

Computer-assisted	NULL
determination	NULL
of	NULL
a	NULL
putative	NULL
consensus	NULL
sequence	NULL
.	NULL

A	NULL
novel	NULL
computer	NULL
algorithm	NULL
has	NULL
been	NULL
developed	NULL
in	NULL
order	NULL
to	NULL
find	NULL
a	NULL
hypothetical	NULL
consensus	NULL
sequence	NULL
description	NULL
for	NULL
the	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
NP-TCy	NULL
,	NULL
.	NULL

The	NULL
principle	NULL
of	NULL
the	NULL
algorithm	NULL
is	NULL
to	NULL
evaluate	NULL
a	NULL
set	NULL
of	NULL
candidate	NULL
motifs	NULL
by	NULL
correlating	NULL
their	NULL
best	NULL
matches	NULL
in	NULL
a	NULL
series	NULL
of	NULL
competitor	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bor	NULL
.	NULL

fragments	NULL
with	NULL
the	NULL
binding	NULL
efficiencies	NULL
of	NULL
these	NULL
fragments	NULL
and	NULL
then	NULL
to	NULL
rank	NULL
them	NULL
by	NULL
a	NULL
quality	NULL
score	NULL
.	NULL

The	NULL
input	NULL
data	NULL
consist	NULL
of	NULL
a	NULL
set	NULL
of	NULL
(	NULL
typically	NULL
short	NULL
)	NULL
DNA	NULL
sequences	NULL
,	NULL
each	NULL
one	NULL
associated	NULL
with	NULL
a	NULL
number	NULL
reflecting	NULL
its	NULL
relative	NULL
protein	NULL
binding	NULL
efficiency	NULL
in	NULL
band	NULL
shift	NULL
experiments	NULL
.	NULL

Here	NULL
,	NULL
these	NULL
numbers	NULL
were	NULL
determined	NULL
by	NULL
titrating	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
unlabelled	NULL
sequences	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
labelled	NULL
TC-II	NULL
probe	NULL
in	NULL
reaction	NULL
mixtures	NULL
containing	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
PC6O	NULL
and	NULL
an	NULL
excess	NULL
of	NULL
TC-II	NULL
probe	NULL
.	NULL

Addition	NULL
of	NULL
5	NULL
M	NULL
excess	NULL
of	NULL
cold	NULL
TC-II	NULL
probe	NULL
reduced	NULL
the	NULL
amount	NULL
of	NULL
specifically	NULL
retarded	NULL
probe	NULL
by	NULL
50	NULL
%	NULL
.	NULL

For	NULL
the	NULL
other	NULL
sequences	NULL
,	NULL
relative	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
amount	NULL
of	NULL
competitor	NULL
needed	NULL
to	NULL
give	NULL
the	NULL
same	NULL
reduction	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
of	NULL
TC-II	NULL
was	NULL
given	NULL
an	NULL
arbitrary	NULL
value	NULL
of	NULL
6	NULL
on	NULL
a	NULL
scale	NULL
in	NULL
which	NULL
a	NULL
difference	NULL
of	NULL
1	NULL
U	NULL
corresponds	NULL
to	NULL
a	NULL
twofold	NULL
change	NULL
in	NULL
competitor	NULL
efficiency	NULL
.	NULL

The	NULL
set	NULL
of	NULL
candidate	NULL
sequence	NULL
motifs	NULL
is	NULL
defined	NULL
by	NULL
the	NULL
length	NULL
(	NULL
/	NULL
)	NULL
of	NULL
the	NULL
motif	NULL
and	NULL
the	NULL
number	NULL
(	NULL
k	NULL
)	NULL
of	NULL
explicitly	NULL
specified	NULL
bases	NULL
(	NULL
A	NULL
,	NULL
C	NULL
,	NULL
G	NULL
,	NULL
and	NULL
T	NULL
)	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
number	NULL
of	NULL
positions	NULL
not	NULL
occupied	NULL
by	NULL
N	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
considered	NULL
all	NULL
motifs	NULL
of	NULL
the	NULL
following	NULL
types	NULL
:	NULL
/	NULL
=	NULL
6	NULL
,	NULL
4	NULL
<	NULL
k	NULL
<	NULL
6,1	NULL
=	NULL
7,4	NULL
sks	NULL
7	NULL
;	NULL
1=	NULL
8,5	NULL
<	NULL
k	NULL
<	NULL
7	NULL
;	NULL
l1=	NULL
9,5	NULL
<	NULL
k	NULL
<	NULL
7	NULL
.	NULL

The	NULL
algorithm	NULL
determines	NULL
for	NULL
each	NULL
competitor	NULL
fragment	NULL
the	NULL
quantity	NULL
m	NULL
,	NULL
,	NULL
,	NULL
defined	NULL
as	NULL
the	NULL
number	NULL
of	NULL
matches	NULL
between	NULL
the	NULL
sequence	NULL
motif	NULL
i	NULL
and	NULL
the	NULL
most	NULL
similar	NULL
subsequence	NULL
in	NULL
fragment	NULL
J	NULL
.	NULL

A	NULL
classical	NULL
correlation	NULL
coefficient	NULL
is	NULL
used	NULL
as	NULL
quality	NULL
score	NULL
for	NULL
ranking	NULL
:	NULL
N	NULL
3	NULL
,	NULL
(	NULL
my	NULL
-	NULL
m	NULL
;	NULL
)	NULL
(	NULL
;	NULL
-	NULL
%	NULL
)	NULL
j=1	NULL
``	NULL
=T	NULL
w	NULL
12	NULL
3	NULL
(	NULL
m	NULL
;	NULL
-my	NULL
3	NULL
(	NULL
-*	NULL
j=l	NULL
j=l	NULL
where	NULL
x	NULL
;	NULL
is	NULL
the	NULL
competitor	NULL
efficiency	NULL
of	NULL
fragment	NULL
j	NULL
and	NULL
N	NULL
is	NULL
the	NULL
number	NULL
of	NULL
fragments	NULL
tested	NULL
.	NULL

The	NULL
software	NULL
performing	NULL
this	NULL
analysis	NULL
is	NULL
available	NULL
under	NULL
the	NULL
name	NULL
CONSCOR	NULL
from	NULL
the	NULL
ftp	NULL
servers	NULL
ncbi.nlm.nih.gov	NULL
(	NULL
130.14.20.1	NULL
)	NULL
at	NULL
the	NULL
National	NULL
Center	NULL
for	NULL
Biotechnology	NULL
Information	NULL
,	NULL
Bethesda	NULL
,	NULL
Md	NULL
.	NULL

,	NULL
and	NULL
expasy.hcuge.ch	NULL
(	NULL
129.195.254.61	NULL
)	NULL
at	NULL
the	NULL
University	NULL
of	NULL
Geneva	NULL
or	NULL
by	NULL
request	NULL
from	NULL
us	NULL
(	NULL
contact	NULL
pbucher	NULL
@	NULL
isrec-sunl.unil.ch	NULL
by	NULL
electronic	NULL
mail	NULL
)	NULL
.	NULL

RESULTS	NULL
Previous	NULL
characterization	NULL
of	NULL
specific	NULL
TC-II	NULL
binding	NULL
proteins	NULL
in	NULL
PC6O	NULL
nuclei	NULL
had	NULL
revealed	NULL
,	NULL
besides	NULL
IL-l-inducible	NULL
NF-	NULL
«	NULL
xB	NULL
,	NULL
complexes	NULL
that	NULL
were	NULL
formed	NULL
by	NULL
extracts	NULL
from	NULL
cells	NULL
growing	NULL
in	NULL
normal	NULL
as	NULL
well	NULL
as	NULL
in	NULL
IL-1-suppilemented	NULL
medium	NULL
(	NULL
10	NULL
)	NULL
.	NULL

We	NULL
call	NULL
the	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
giving	NULL
rise	NULL
to	NULL
these	NULL
complexes	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
complexes	NULL
is	NULL
specifically	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
unlabelled	NULL
TC-II	NULL
DNA	NULL
.	NULL

As	NULL
described	NULL
previously	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
nucle-otides	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
strongly	NULL
reduces	NULL
the	NULL
NP-TC	NULL
,	NULL
band	NULL
shift	NULL
but	NULL
has	NULL
the	NULL
opposite	NULL
effect	NULL
on	NULL
NF-kB	NULL
.	NULL

Both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
complexes	NULL
are	NULL
heat	NULL
labile	NULL
,	NULL
since	NULL
incubation	NULL
for	NULL
5	NULL
min	NULL
at	NULL
65°C	NULL
completely	NULL
suppresses	NULL
their	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

They	NULL
have	NULL
similar	NULL
electrophoretic	NULL
mobilities	NULL
,	NULL
but	NULL
the	NULL
latter	NULL
shows	NULL
a	NULL
much	NULL
more	NULL
heterogeneous	NULL
pattern	NULL
.	NULL

This	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
due	NULL
to	NULL
proteolytic	NULL
degradation	NULL
during	NULL
nuclear	NULL
extraction	NULL
,	NULL
as	NULL
it	NULL
is	NULL
not	NULL
reduced	NULL
by	NULL
different	NULL
protease	NULL
inhibi-tors	NULL
(	NULL
0.2	NULL
wM	NULL
aprotinin	NULL
;	NULL
200	NULL
wM	NULL
phenylmethylsulfonyl	NULL
fluo-ride	NULL
;	NULL
and	NULL
1	NULL
mM	NULL
each	NULL
pepstatin	NULL
,	NULL
antipain	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
chymostatin	NULL
)	NULL
.	NULL

Attempts	NULL
to	NULL
reduce	NULL
heterogeneity	NULL
by	NULL
changing	NULL
composition	NULL
of	NULL
the	NULL
binding	NULL
reaction	NULL
or	NULL
electrophoresis	NULL
buff-ers	NULL
,	NULL
acrylamide	NULL
percentage	NULL
,	NULL
or	NULL
migration	NULL
conditions	NULL
were	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
I-	NULL
I+	NULL
.20	NULL
.25	NULL
.30	NULL
.35	NULL
40	NULL
45	NULL
.50	NULL
.60	NULL
.70	NULL
M	NULL
KCI	NULL
ts	NULL
A	NULL
Woos	NULL
qee	NULL
ter	NULL
eee	NULL
wees	NULL
€	NULL
NF-	NULL
«	NULL
B	NULL
Jo	NULL
ann	NULL
|	NULL
Nol	NULL
(	NULL
0B	NULL
fs	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Heparin	NULL
chromatography	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
with	NULL
TC-II	NULL
probe	NULL
of	NULL
heparin-agarose	NULL
chromatography	NULL
fractions	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
IL-l-treated	NULL
PC60	NULL
cells	NULL
,	NULL
assayed	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
A	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
B	NULL
)	NULL
of	NULL
ATP	NULL
.	NULL

I	NULL
,	NULL
column	NULL
input	NULL
without	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
(	NULL
+	NULL
)	NULL
ATP	NULL
;	NULL
0.20	NULL
to	NULL
0.70	NULL
,	NULL
KCI	NULL
concentration	NULL
(	NULL
M	NULL
)	NULL
in	NULL
elution	NULL
buffer	NULL
.	NULL

unsuccessful	NULL
.	NULL

NP-TC	NULL
;	NULL
,	NULL
,	NULL
complexes	NULL
were	NULL
not	NULL
retained	NULL
on	NULL
a	NULL
wheat	NULL
germ	NULL
agglutinin	NULL
column	NULL
which	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
bound	NULL
glycosylated	NULL
Sp1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

During	NULL
heparin	NULL
chroma-tography	NULL
,	NULL
NF-KB	NULL
elutes	NULL
at	NULL
between	NULL
0.35	NULL
and	NULL
0.50	NULL
M	NULL
KCl	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
54	NULL
)	NULL
,	NULL
whereas	NULL
NP-TC	NULL
;	NULL
,	NULL
starts	NULL
to	NULL
elute	NULL
already	NULL
at	NULL
0.25	NULL
M	NULL
KCl	NULL
,	NULL
with	NULL
a	NULL
peak	NULL
at	NULL
0.30	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
heparin-fractionated	NULL
NP-TC	NULL
}	NULL
;	NULL
,	NULL
gives	NULL
DNA-binding	NULL
complexes	NULL
that	NULL
migrate	NULL
slightly	NULL
faster	NULL
than	NULL
complexes	NULL
formed	NULL
by	NULL
un-fractionated	NULL
material	NULL
.	NULL

We	NULL
have	NULL
no	NULL
explanation	NULL
for	NULL
this	NULL
reproducible	NULL
change	NULL
,	NULL
which	NULL
is	NULL
not	NULL
prevented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
various	NULL
protease	NULL
inhibitors	NULL
.	NULL

NP-TC	NULL
,	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
yield	NULL
distinct	NULL
tryptic	NULL
DNA-binding	NULL
fragments	NULL
.	NULL

Limited	NULL
trypsin	NULL
digestion	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
produces	NULL
two	NULL
major	NULL
DNA-binding	NULL
fragments	NULL
,	NULL
x1	NULL
and	NULL
x2	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
only	NULL
fragment	NULL
«	NULL
1	NULL
is	NULL
present	NULL
after	NULL
trypsin	NULL
diges-	NULL
PCGO	NULL
PC6O	NULL
+	NULL
IL1	NULL
702	NULL
/	NULL
3	NULL
+	NULL
IL1	NULL
a-	NULL
1	NULL
[	NULL
TRYPS	NULL
1	NULL
-	NULL
&	NULL
%	NULL
%	NULL
-	NULL
$	NULL
o	NULL
-o	NULL
#	NULL
-o	NULL
+	NULL
+o	NULL
+	NULL
#	NULL
+0	NULL
+o	NULL
+	NULL
#	NULL
ATP	NULL
:	NULL
.	NULL

.	NULL

.	NULL

s	NULL
q	NULL
o	NULL
soos	NULL
o	NULL
$	NULL
oo	NULL
odo	NULL
to	NULL
oto	NULL
t	NULL
ob	NULL
o	NULL
%	NULL
COMP	NULL
:	NULL
w	NULL
m	NULL
w	NULL
m	NULL
w	NULL
oe	NULL
0	NULL
v0	NULL
-	NULL
e	NULL
h	NULL
wap	NULL
‘	NULL
C	NULL
C+	NULL
P	NULL
wie	NULL
'	NULL
<	NULL
x2	NULL
T	NULL
:	NULL
>	NULL
‘	NULL
me	NULL
T	NULL
>	NULL
w	NULL
Sits	NULL
*	NULL
»	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

NP-TC	NULL
;	NULL
,	NULL
and	NULL
NF-kB	NULL
and	NULL
their	NULL
DNA-binding	NULL
trypsin	NULL
fragments	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
PC60	NULL
or	NULL
70Z2/3	NULL
cells	NULL
,	NULL
cultured	NULL
in	NULL
normal	NULL
or	NULL
in	NULL
IL-1-supplemented	NULL
medium	NULL
,	NULL
were	NULL
treated	NULL
for	NULL
5	NULL
min	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
trypsin	NULL
per	NULL
ml	NULL
.	NULL

Undigested	NULL
and	NULL
trypsin	NULL
(	NULL
TRYPS	NULL
)	NULL
-treated	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
TC-II	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ATP	NULL
and/or	NULL
a	NULL
45-fold	NULL
excess	NULL
of	NULL
unlabelled	NULL
competitor	NULL
(	NULL
COMP	NULL
)	NULL
DNA	NULL
containing	NULL
the	NULL
wild-type	NULL
TC-II	NULL
motif	NULL
(	NULL
w	NULL
)	NULL
or	NULL
the	NULL
mutant	NULL
TC-42	NULL
(	NULL
m	NULL
)	NULL
.	NULL

Retarded	NULL
complexes	NULL
were	NULL
detected	NULL
on	NULL
a	NULL
nonde-naturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

«	NULL
1	NULL
and	NULL
2	NULL
,	NULL
complexes	NULL
formed	NULL
by	NULL
trypsin	NULL
fragments	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
Tl	NULL
and	NULL
T2	NULL
,	NULL
complexes	NULL
formed	NULL
by	NULL
trypsin	NULL
fragments	NULL
of	NULL
NP-TC	NULL
;	NULL
;	NULL
;	NULL
F	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

TRANSCRIPTION	NULL
FACTOR	NULL
NP-TC	NULL
;	NULL
,	NULL
5219	NULL
A	NULL
B	NULL
¢	NULL
b	NULL
#	NULL
wy	NULL
km	NULL
:	NULL
-	NULL
o	NULL
a808	NULL
fraction	NULL
L	NULL
14	NULL
16	NULL
18	NULL
20	NULL
22	NULL
L	NULL
14	NULL
16	NULL
18	NULL
20	NULL
22	NULL
Thyrogl	NULL
.	NULL

Ferritin	NULL
668	NULL
KD	NULL
439	NULL
KD	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Gel	NULL
filtration	NULL
chromatography	NULL
of	NULL
Nuclear	NULL
extract	NULL
from	NULL
ELA	NULL
cells	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
calibrated	NULL
Superose	NULL
column	NULL
.	NULL

TC-II	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
indicated	NULL
fractions	NULL
was	NULL
assayed	NULL
by	NULL
gel	NULL
retardation	NULL
before	NULL
(	NULL
A	NULL
)	NULL
or	NULL
after	NULL
(	NULL
B	NULL
)	NULL
trypsin	NULL
digestion	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
here	NULL
is	NULL
the	NULL
tetramerized	NULL
wild-type	NULL
TC-II	NULL
motif	NULL
,	NULL
and	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
bands	NULL
,	NULL
a	NULL
and	NULL
a	NULL
'	NULL
,	NULL
are	NULL
due	NULL
to	NULL
complexes	NULL
containing	NULL
more	NULL
than	NULL
one	NULL
NP-TC	NULL
;	NULL
;	NULL
molecule	NULL
.	NULL

Thyrogl	NULL
.	NULL

,	NULL
thyroglobu-lin	NULL
;	NULL
b	NULL
,	NULL
complexes	NULL
containing	NULL
a	NULL
single	NULL
NP-TC	NULL
;	NULL
;	NULL
molecule	NULL
;	NULL
T	NULL
;	NULL
and	NULL
T	NULL
;	NULL
,	NULL
complexes	NULL
due	NULL
to	NULL
trypsin	NULL
fragments	NULL
of	NULL
NP-TCJ	NULL
.	NULL

tion	NULL
(	NULL
for	NULL
examples	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Trypsin-treated	NULL
nuclear	NULL
extracts	NULL
from	NULL
noninduced	NULL
and	NULL
IL-1-treated	NULL
PC6O	NULL
cells	NULL
form	NULL
two	NULL
major	NULL
specific	NULL
complexes	NULL
with	NULL
the	NULL
TC-II	NULL
probe	NULL
(	NULL
Tl	NULL
and	NULL
T2	NULL
)	NULL
that	NULL
migrate	NULL
faster	NULL
than	NULL
the	NULL
ones	NULL
due	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
fragments	NULL
.	NULL

As	NULL
for	NULL
NP-TC	NULL
,	NULL
,	NULL
,	NULL
the	NULL
Tl	NULL
and	NULL
T2	NULL
complexes	NULL
are	NULL
inhibited	NULL
by	NULL
ATP	NULL
,	NULL
and	NULL
comparison	NULL
of	NULL
the	NULL
fine	NULL
specificities	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
clearly	NULL
shows	NULL
that	NULL
Tl	NULL
and	NULL
T2	NULL
are	NULL
derived	NULL
from	NULL
NP-TC	NULL
;	NULL
,	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
what	NULL
the	NULL
relationship	NULL
between	NULL
Tl	NULL
and	NULL
T2	NULL
is	NULL
.	NULL

Digestion	NULL
kinetics	NULL
do	NULL
not	NULL
provide	NULL
any	NULL
evidence	NULL
that	NULL
Tl	NULL
might	NULL
be	NULL
a	NULL
precursor	NULL
of	NULL
T2	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
relative	NULL
predominance	NULL
of	NULL
T1	NULL
and	NULL
T2	NULL
consistently	NULL
varies	NULL
among	NULL
different	NULL
cell	NULL
lines	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

NP-TC	NULL
,	NULL
,	NULL
consists	NULL
of	NULL
heterogeneous	NULL
proteins	NULL
with	NULL
the	NULL
same	NULL
DNA-binding	NULL
moieties	NULL
or	NULL
domains	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
heterogeneity	NULL
of	NULL
NP-TC	NULL
,	NULL
,	NULL
complexes	NULL
observed	NULL
on	NULL
nondena-turing	NULL
band	NULL
shift	NULL
gels	NULL
reflects	NULL
size	NULL
heterogeneity	NULL
of	NULL
the	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
we	NULL
fractionated	NULL
nuclear	NULL
extract	NULL
from	NULL
NP-TC	NULL
;	NULL
,	NULL
containing	NULL
EL4	NULL
thymoma	NULL
cells	NULL
on	NULL
a	NULL
Superose	NULL
column	NULL
.	NULL

Figure	NULL
3A	NULL
shows	NULL
that	NULL
NP-TC	NULL
;	NULL
,	NULL
activity	NULL
coelutes	NULL
with	NULL
proteins	NULL
with	NULL
molecular	NULL
masses	NULL
of	NULL
between	NULL
550	NULL
and	NULL
370	NULL
kDa	NULL
.	NULL

There	NULL
is	NULL
a	NULL
good	NULL
correlation	NULL
between	NULL
elution	NULL
volume	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
complexes	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
heterogeneity	NULL
in	NULL
the	NULL
band	NULL
shift	NULL
pattern	NULL
is	NULL
due	NULL
to	NULL
molecular	NULL
weight	NULL
variation	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
.	NULL

All	NULL
fractions	NULL
,	NULL
when	NULL
digested	NULL
with	NULL
trypsin	NULL
,	NULL
gave	NULL
rise	NULL
to	NULL
the	NULL
Tl	NULL
and	NULL
T2	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Attempts	NULL
to	NULL
dissociate	NULL
possible	NULL
oligomeric	NULL
complexes	NULL
,	NULL
by	NULL
treatment	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
deoxycholate	NULL
(	NULL
DOC	NULL
)	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
Nonidet	NULL
P-40	NULL
,	NULL
were	NULL
unsuccessful	NULL
.	NULL

Beyond	NULL
concentrations	NULL
of	NULL
2	NULL
%	NULL
DOC	NULL
,	NULL
binding	NULL
activity	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
was	NULL
gradually	NULL
inhib-ited	NULL
,	NULL
but	NULL
no	NULL
shift	NULL
to	NULL
a	NULL
faster-migrating	NULL
complex	NULL
was	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NP-TC	NULL
;	NULL
,	NULL
,	NULL
activity	NULL
is	NULL
restricted	NULL
principally	NULL
to	NULL
lymphocytes	NULL
.	NULL

NP-TC	NULL
;	NULL
,	NULL
was	NULL
first	NULL
observed	NULL
in	NULL
extracts	NULL
of	NULL
PC6O	NULL
cells	NULL
which	NULL
have	NULL
phenotypic	NULL
characteristics	NULL
of	NULL
immature	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
pre-B-cell	NULL
line	NULL
70Z	NULL
,	NULL
/3	NULL
and	NULL
HeLa	NULL
cells	NULL
contained	NULL
no	NULL
detectable	NULL
NP-TC	NULL
;	NULL
,	NULL
activity	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
a	NULL
restricted	NULL
tissue	NULL
distribution	NULL
of	NULL
NP-TC	NULL
,	NULL
,	NULL
DNA-binding	NULL
activity	NULL
.	NULL

To	NULL
investi-	NULL
5220	NULL
LATTION	NULL
ET	NULL
AL	NULL
.	NULL

EXTRACT	NULL
EL4	NULL
BW5147	NULL
m	NULL
®	NULL
m	NULL
h	NULL
m	NULL
NP-TC	NULL
j	NULL
{	NULL
NF-xB	NULL
*~	NULL
``	NULL
Te	NULL
TT	NULL
e	NULL
|	NULL
|	NULL
|	NULL
|	NULL
K562	NULL
Gun—	NULL
”	NULL
J	NULL
D	NULL
I	NULL
b	NULL
duck	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

BW514	NULL
CTLL	NULL
EL4	NULL
Raji	NULL
BB	NULL
m	NULL
m	NULL
h	NULL
m	NULL
ATP	NULL
Cit	NULL
COMP	NULL
+	NULL
+	NULL
+	NULL
|	NULL
||	NULL
|	NULL
||	NULL
||	NULL
||	NULL
K1	NULL
-	NULL
»	NULL
|	NULL
i	NULL
|	NULL
.l	NULL
-	NULL
<	NULL
-K	NULL
;	NULL
*	NULL
e	NULL
BL	NULL
_	NULL
|	NULL
-	NULL
<	NULL
s-T	NULL
Ti	NULL
-	NULL
»	NULL
|	NULL
_	NULL
T	NULL
T3	NULL
-e	NULL
1	NULL
|	NULL
||	NULL
|	NULL
|	NULL
|	NULL
E|	NULL
|	NULL
<	NULL
-r	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

NP-TC	NULL
,	NULL
,	NULL
binding	NULL
activity	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

TC-II	NULL
complexes	NULL
formed	NULL
by	NULL
nondigested	NULL
(	NULL
A	NULL
)	NULL
or	NULL
trypsin-treated	NULL
(	NULL
B	NULL
to	NULL
E	NULL
)	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
(	NULL
h	NULL
)	NULL
or	NULL
mouse	NULL
(	NULL
m	NULL
)	NULL
cell	NULL
lines	NULL
or	NULL
normal	NULL
mouse	NULL
lymphocytes	NULL
(	NULL
E	NULL
)	NULL
,	NULL
without	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
M	NULL
excess	NULL
of	NULL
unlabelled	NULL
TC-II	NULL
sequence	NULL
(	NULL
COMP	NULL
)	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
;	NULL
(	NULL
C	NULL
)	NULL
nonlymphoid	NULL
hemopoietic	NULL
cells	NULL
;	NULL
(	NULL
D	NULL
)	NULL
nonhemopoietic	NULL
cells	NULL
;	NULL
(	NULL
E	NULL
)	NULL
normal	NULL
mouse	NULL
lymphocytes	NULL
.	NULL

gate	NULL
its	NULL
tissue	NULL
specificity	NULL
,	NULL
we	NULL
screened	NULL
nuclear	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
lines	NULL
and	NULL
normal	NULL
tissues	NULL
for	NULL
NP-TC	NULL
;	NULL
,	NULL
activity	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
normal	NULL
medium	NULL
or	NULL
stimulated	NULL
with	NULL
IL-1	NULL
or	NULL
TNF	NULL
.	NULL

Untreated	NULL
or	NULL
trypsin-digested	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
band	NULL
shift	NULL
assays	NULL
with	NULL
the	NULL
TC-II	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
presumptive	NULL
NP-TC	NULL
;	NULL
;	NULL
activity	NULL
was	NULL
tested	NULL
by	NULL
addition	NULL
of	NULL
unlabelled	NULL
TC-II	NULL
competitor	NULL
.	NULL

Results	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
strong	NULL
constitutive	NULL
NF-kB	NULL
activity	NULL
was	NULL
found	NULL
in	NULL
all	NULL
B-cell	NULL
lines	NULL
.	NULL

Extracts	NULL
from	NULL
most	NULL
T-cell	NULL
lines	NULL
also	NULL
contained	NULL
detectable	NULL
constitutive	NULL
NF-kB	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
10	NULL
,	NULL
33	NULL
)	NULL
,	NULL
IL-1	NULL
or	NULL
TNF	NULL
a	NULL
strongly	NULL
increased	NULL
NF-KB	NULL
activity	NULL
in	NULL
almost	NULL
all	NULL
T-cell	NULL
lines	NULL
and	NULL
induced	NULL
its	NULL
appearance	NULL
in	NULL
most	NULL
NF-	NULL
«	NULL
B-negative	NULL
cells	NULL
regardless	NULL
of	NULL
tissue	NULL
origin	NULL
.	NULL

Constitutive	NULL
NP-TC	NULL
;	NULL
;	NULL
binding	NULL
activity	NULL
is	NULL
present	NULL
in	NULL
extracts	NULL
of	NULL
all	NULL
human	NULL
and	NULL
rodent	NULL
T-cell	NULL
lines	NULL
tested	NULL
.	NULL

NP-TC	NULL
;	NULL
,	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
all	NULL
pre-B-	NULL
and	NULL
mature	NULL
B-cell	NULL
lines	NULL
tested	NULL
.	NULL

70Z7/3	NULL
cells	NULL
contain	NULL
little	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
activity	NULL
.	NULL

Although	NULL
there	NULL
was	NULL
some	NULL
variation	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobilities	NULL
of	NULL
undigested	NULL
NP-TC	NULL
;	NULL
,	NULL
from	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
,	NULL
complexes	NULL
Tl	NULL
and	NULL
T2	NULL
formed	NULL
by	NULL
trypsin-treated	NULL
extracts	NULL
migrated	NULL
with	NULL
the	NULL
same	NULL
mobilities	NULL
.	NULL

However	NULL
,	NULL
there	NULL
were	NULL
notable	NULL
differences	NULL
in	NULL
the	NULL
relative	NULL
abundances	NULL
of	NULL
Tl	NULL
and	NULL
T2	NULL
.	NULL

Mouse	NULL
Tl	NULL
and	NULL
T2	NULL
,	NULL
as	NULL
well	NULL
as	NULL
«	NULL
1	NULL
complexes	NULL
,	NULL
migrate	NULL
slightly	NULL
faster	NULL
than	NULL
their	NULL
human	NULL
counterparts	NULL
.	NULL

Among	NULL
normal	NULL
mouse	NULL
lymphocytes	NULL
,	NULL
thymocytes	NULL
are	NULL
quite	NULL
rich	NULL
in	NULL
Splenic	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
contained	NULL
both	NULL
NF-kB	NULL
and	NULL
NP-TC	NULL
,	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
predominated	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
T	NULL
cells	NULL
contain	NULL
more	NULL
NP-TCJ	NULL
,	NULL
.	NULL

We	NULL
could	NULL
detect	NULL
strong	NULL
NP-TC	NULL
,	NULL
plike	NULL
activity	NULL
also	NULL
in	NULL
extracts	NULL
from	NULL
K562	NULL
,	NULL
a	NULL
cell	NULL
line	NULL
representing	NULL
precursors	NULL
of	NULL
the	NULL
erythrocytic	NULL
,	NULL
granulocytic	NULL
,	NULL
and	NULL
monocytic	NULL
lineages	NULL
.	NULL

Other	NULL
cell	NULL
lines	NULL
belonging	NULL
to	NULL
the	NULL
monocyte-macrophage	NULL
lineage	NULL
or	NULL
representing	NULL
myeloid	NULL
precursor	NULL
stages	NULL
contained	NULL
small	NULL
amounts	NULL
of	NULL
NP-TC	NULL
;	NULL
;	NULL
-like	NULL
activity	NULL
.	NULL

In	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
of	NULL
nonhematopoietic	NULL
origin	NULL
,	NULL
we	NULL
detected	NULL
no	NULL
NP-TC	NULL
;	NULL
,	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

We	NULL
found	NULL
some	NULL
activity	NULL
in	NULL
the	NULL
rat	NULL
hepatoma	NULL
cell	NULL
line	NULL
Fao	NULL
but	NULL
not	NULL
in	NULL
HepG2	NULL
,	NULL
a	NULL
human	NULL
hepatoma	NULL
,	NULL
or	NULL
in	NULL
mouse	NULL
liver	NULL
extract	NULL
.	NULL

Treatment	NULL
with	NULL
IL-1	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
NP-TC	NULL
;	NULL
,	NULL
activity	NULL
in	NULL
any	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

NP-TC	NULL
,	NULL
,	NULL
and	NULL
NF-B	NULL
differ	NULL
in	NULL
their	NULL
fine	NULL
specificities	NULL
.	NULL

Both	NULL
NP-TC	NULL
;	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
xB	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
TC-II	NULL
motif	NULL
.	NULL

To	NULL
compare	NULL
more	NULL
precisely	NULL
the	NULL
sequence	NULL
specificities	NULL
of	NULL
NF-kB	NULL
and	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
,	NULL
we	NULL
used	NULL
TC-II	NULL
oligonucleotides	NULL
containing	NULL
single	NULL
point	NULL
mutations	NULL
in	NULL
each	NULL
of	NULL
the	NULL
13	NULL
bp	NULL
forming	NULL
the	NULL
TC-II	NULL
motif	NULL
of	NULL
SV40	NULL
as	NULL
competitors	NULL
for	NULL
the	NULL
TC-II	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
revealed	NULL
an	NULL
overall	NULL
similarity	NULL
,	NULL
but	NULL
also	NULL
some	NULL
clear	NULL
differences	NULL
,	NULL
between	NULL
the	NULL
specificities	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
both	NULL
factors	NULL
is	NULL
reduced	NULL
by	NULL
mutations	NULL
in	NULL
nt	NULL
242	NULL
to	NULL
245	NULL
and	NULL
somewhat	NULL
less	NULL
by	NULL
mutations	NULL
in	NULL
nt	NULL
241	NULL
and	NULL
239	NULL
.	NULL

However	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
is	NULL
also	NULL
reduced	NULL
by	NULL
an	NULL
alteration	NULL
of	NULL
nt	NULL
236	NULL
and	NULL
is	NULL
most	NULL
strongly	NULL
diminished	NULL
by	NULL
the	NULL
mutations	NULL
in	NULL
nt	NULL
237	NULL
.	NULL

These	NULL
two	NULL
mutations	NULL
have	NULL
no	NULL
or	NULL
only	NULL
a	NULL
marginal	NULL
effect	NULL
on	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
binding	NULL
.	NULL

The	NULL
point	NULL
mutations	NULL
have	NULL
the	NULL
same	NULL
effect	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NP-TC	NULL
;	NULL
,	NULL
as	NULL
on	NULL
that	NULL
of	NULL
their	NULL
proteolytic	NULL
fragments	NULL
(	NULL
Tl	NULL
and	NULL
T2	NULL
for	NULL
NP-TC	NULL
;	NULL
,	NULL
and	NULL
«	NULL
1	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
.	NULL

This	NULL
validates	NULL
the	NULL
assignment	NULL
of	NULL
the	NULL
origin	NULL
of	NULL
the	NULL
tryptic	NULL
DNA-binding	NULL
fragments	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
confirm	NULL
earlier	NULL
studies	NULL
by	NULL
Macchi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
25	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
shown	NULL
that	NULL
G237	NULL
,	NULL
G238	NULL
,	NULL
and	NULL
G240	NULL
were	NULL
protected	NULL
against	NULL
DNase	NULL
I	NULL
cleavage	NULL
and	NULL
methylation	NULL
by	NULL
dimethyl	NULL
sulfate	NULL
(	NULL
DMS	NULL
)	NULL
only	NULL
by	NULL
extracts	NULL
from	NULL
IL-1-treated	NULL
PC6O	NULL
cells	NULL
,	NULL
whereas	NULL
G244	NULL
and	NULL
G245	NULL
were	NULL
protected	NULL
by	NULL
extracts	NULL
from	NULL
both	NULL
induced	NULL
and	NULL
uninduced	NULL
cells	NULL
.	NULL

This	NULL
agrees	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
TRANSCRIPTION	NULL
FACTOR	NULL
NP-TC	NULL
;	NULL
5221	NULL
TABLE	NULL
1	NULL
.	NULL

Tissue	NULL
distribution	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
``	NULL
Activity	NULL
of	NULL
:	NULL
.	NULL

Reference	NULL
no	NULL
.	NULL

or	NULL
Cell	NULL
type	NULL
Species	NULL
Name	NULL
ATCC	NULL
designation	NULL
``	NULL
NP-TC	NULL
;	NULL
,	NULL
NF-kB°	NULL
-IL1	NULL
+IL1	NULL
Lymphoid	NULL
cells	NULL
Pre-T	NULL
cells	NULL
Rat	NULL
C58	NULL
(	NULL
11	NULL
)	NULL
+++	NULL
+	NULL
+	NULL
Mouse	NULL
MbC12	NULL
(	NULL
29	NULL
)	NULL
+++	NULL
(	NULL
+	NULL
)	NULL
+	NULL
BW5147	NULL
TIB	NULL
47	NULL
+++	NULL
+	NULL
+	NULL
T	NULL
cells	NULL
Human	NULL
HSB-2	NULL
CCL	NULL
120.1	NULL
++	NULL
+	NULL
+	NULL
Jurkat	NULL
(	NULL
19	NULL
)	NULL
+++	NULL
-	NULL
KT	NULL
(	NULL
22	NULL
)	NULL
++	NULL
-	NULL
+	NULL
Mouse	NULL
B6.1	NULL
(	NULL
51	NULL
)	NULL
++	NULL
+	NULL
+	NULL
CTLL	NULL
TIB	NULL
214	NULL
+++	NULL
+	NULL
+	NULL
ELA	NULL
TIB	NULL
39	NULL
+++	NULL
-	NULL
+	NULL
$	NULL
49	NULL
TIB	NULL
28	NULL
++	NULL
+	NULL
(	NULL
+	NULL
)	NULL
PbCS.F12	NULL
(	NULL
36	NULL
)	NULL
++	NULL
+	NULL
+	NULL
Pre-B	NULL
cells	NULL
Human	NULL
Nalm1l	NULL
(	NULL
26	NULL
)	NULL
++	NULL
+	NULL
+	NULL
Mouse	NULL
70Z/3	NULL
TIB	NULL
158	NULL
+	NULL
+	NULL
+	NULL
B	NULL
cells	NULL
Human	NULL
Raji	NULL
CCL	NULL
86	NULL
+++	NULL
+	NULL
+	NULL
Daudi	NULL
CCL	NULL
213	NULL
+++	NULL
+	NULL
+	NULL
Namatwa	NULL
CRL	NULL
1432	NULL
++	NULL
+	NULL
+	NULL
SB	NULL
CCL	NULL
120	NULL
+	NULL
+	NULL
+	NULL
Mouse	NULL
LBB	NULL
(	NULL
31	NULL
)	NULL
++	NULL
+	NULL
+	NULL
A20.2J	NULL
(	NULL
14	NULL
)	NULL
++	NULL
+	NULL
+	NULL
PC6éL	NULL
TIB	NULL
222	NULL
++	NULL
+	NULL
+	NULL
P3X63Ag8	NULL
TIB	NULL
9	NULL
+	NULL
+	NULL
+	NULL
Other	NULL
hemopoietic	NULL
cells	NULL
Myeloid	NULL
Human	NULL
K562	NULL
CCL	NULL
243	NULL
++	NULL
+	NULL
+	NULL
Granulocyte	NULL
precursor	NULL
Mouse	NULL
FDC-P	NULL
(	NULL
9	NULL
)	NULL
(	NULL
+	NULL
)	NULL
-	NULL
+	NULL
Promyelocytic	NULL
Human	NULL
HL-60	NULL
CCL	NULL
240	NULL
(	NULL
+	NULL
)	NULL
-	NULL
Monocytic	NULL
Human	NULL
U-937	NULL
CRL	NULL
1593	NULL
(	NULL
+	NULL
)	NULL
(	NULL
+	NULL
)	NULL
+	NULL
Macrophages	NULL
Mouse	NULL
P388	NULL
CCL	NULL
46	NULL
(	NULL
+	NULL
)	NULL
-	NULL
Mastocytoma	NULL
Mouse	NULL
P815	NULL
TIB	NULL
64	NULL
(	NULL
+	NULL
)	NULL
-	NULL
+	NULL
Nonhemopoietic	NULL
cells	NULL
Cervical	NULL
carcinoma	NULL
Human	NULL
HeLa	NULL
CCL	NULL
2	NULL
-	NULL
+	NULL
+	NULL
Fibrosarcoma	NULL
Human	NULL
HT-1080	NULL
CCL	NULL
121	NULL
-	NULL
(	NULL
+	NULL
)	NULL
+	NULL
Hepatomas	NULL
Human	NULL
HepG2	NULL
HB	NULL
8065	NULL
-	NULL
+	NULL
+	NULL
Rat	NULL
Fao	NULL
(	NULL
12	NULL
)	NULL
+	NULL
-	NULL
+	NULL
Pancreas	NULL
tumor	NULL
Rat	NULL
AR42J	NULL
CRL	NULL
1492	NULL
-	NULL
-	NULL
Fibroblasts	NULL
Human	NULL
FEK4	NULL
(	NULL
50	NULL
)	NULL
-	NULL
(	NULL
+	NULL
)	NULL
+	NULL
Monkey	NULL
CoOS-1	NULL
,	NULL
COS-7	NULL
CRL	NULL
1650	NULL
,	NULL
1651	NULL
-	NULL
-	NULL
+	NULL
Mouse	NULL
wWOP32	NULL
,	NULL
3027	NULL
(	NULL
8	NULL
)	NULL
-	NULL
+	NULL
+	NULL
L-cell	NULL
CRL	NULL
6362	NULL
-	NULL
(	NULL
+	NULL
)	NULL
+	NULL
``	NULL
Results	NULL
of	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

Abundance	NULL
of	NULL
constitutive	NULL
NP-TC	NULL
;	NULL
;	NULL
is	NULL
estimated	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
NF-KB	NULL
is	NULL
also	NULL
indicated	NULL
.	NULL

Symbols	NULL
:	NULL
+++	NULL
,	NULL
strong	NULL
;	NULL
++	NULL
,	NULL
medium	NULL
;	NULL
+	NULL
,	NULL
weak	NULL
;	NULL
(	NULL
+	NULL
)	NULL
,	NULL
barely	NULL
detectable	NULL
activity	NULL
;	NULL
-	NULL
,	NULL
not	NULL
detectable	NULL
.	NULL

®	NULL
Reference	NULL
numbers	NULL
are	NULL
in	NULL
parentheses	NULL
.	NULL

©	NULL
Note	NULL
that	NULL
IL-1	NULL
treatment	NULL
strongly	NULL
increased	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
most	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
in	NULL
the	NULL
band	NULL
shifts	NULL
shown	NULL
,	NULL
constitutive	NULL
and	NULL
induced	NULL
NF-KB	NULL
activities	NULL
can	NULL
not	NULL
be	NULL
compared	NULL
because	NULL
of	NULL
the	NULL
addition	NULL
of	NULL
ATP	NULL
only	NULL
to	NULL
induced	NULL
extracts	NULL
.	NULL

with	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
nt	NULL
237	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
and	NULL
DMS	NULL
methylation	NULL
protection	NULL
performed	NULL
with	NULL
heparin-fractionated	NULL
NP-TC	NULL
;	NULL
,	NULL
from	NULL
ELA	NULL
cells	NULL
confirmed	NULL
these	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
TC-II	NULL
site	NULL
(	NULL
nt	NULL
236	NULL
to	NULL
249	NULL
)	NULL
,	NULL
a	NULL
region	NULL
between	NULL
nt	NULL
261	NULL
and	NULL
288	NULL
on	NULL
the	NULL
late	NULL
strand	NULL
was	NULL
protected	NULL
from	NULL
DNase	NULL
I.	NULL
DMS	NULL
treatment	NULL
revealed	NULL
that	NULL
NP-TC	NULL
,	NULL
,	NULL
bound	NULL
to	NULL
each	NULL
of	NULL
the	NULL
three	NULL
repeats	NULL
of	NULL
the	NULL
motif	NULL
G	NULL
(	NULL
T/C	NULL
)	NULL
GGAA	NULL
(	NULL
T/A	NULL
)	NULL
G	NULL
(	NULL
TC-II	NULL
,	NULL
site	NULL
I	NULL
,	NULL
and	NULL
site	NULL
II	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
TC-II	NULL
and	NULL
site	NULL
I	NULL
,	NULL
the	NULL
first	NULL
guanine	NULL
in	NULL
the	NULL
repeat	NULL
is	NULL
also	NULL
protected	NULL
,	NULL
whereas	NULL
the	NULL
last	NULL
guanine	NULL
is	NULL
hypermethylated	NULL
in	NULL
TC-II	NULL
and	NULL
site	NULL
II	NULL
.	NULL

Consensus	NULL
sequence	NULL
for	NULL
NP-TC	NULL
,	NULL
,	NULL
.	NULL

We	NULL
searched	NULL
for	NULL
binding	NULL
sites	NULL
in	NULL
a	NULL
number	NULL
of	NULL
sequences	NULL
from	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
of	NULL
cellular	NULL
promoters	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
by	NULL
testing	NULL
their	NULL
capacity	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
TC-II	NULL
probe	NULL
.	NULL

We	NULL
used	NULL
these	NULL
data	NULL
,	NULL
together	NULL
with	NULL
similar	NULL
data	NULL
from	NULL
the	NULL
TC-II	NULL
point	NULL
mutations	NULL
TC-33	NULL
to	NULL
-46	NULL
,	NULL
to	NULL
derive	NULL
a	NULL
consensus	NULL
NP-TC	NULL
;	NULL
,	NULL
binding	NULL
sequence	NULL
by	NULL
applying	NULL
to	NULL
them	NULL
the	NULL
novel	NULL
computer	NULL
algorithm	NULL
CONSCOR	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
competition	NULL
efficiency	NULL
estimates	NULL
for	NULL
the	NULL
point	NULL
mutations	NULL
were	NULL
6	NULL
for	NULL
TC-40	NULL
;	NULL
5	NULL
for	NULL
TC-34	NULL
,	NULL
-35	NULL
,	NULL
-36	NULL
,	NULL
-38	NULL
,	NULL
and	NULL
-46	NULL
;	NULL
4	NULL
for	NULL
TC-33	NULL
and	NULL
-37	NULL
;	NULL
3	NULL
for	NULL
TC-39	NULL
and	NULL
-41	NULL
;	NULL
and	NULL
1	NULL
for	NULL
TC-42	NULL
,	NULL
-43	NULL
,	NULL
-44	NULL
,	NULL
and	NULL
-45	NULL
.	NULL

The	NULL
efficiencies	NULL
of	NULL
the	NULL
other	NULL
fragments	NULL
are	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

A	NULL
comprehensive	NULL
collection	NULL
of	NULL
candidate	NULL
sequence	NULL
motifs	NULL
between	NULL
6	NULL
and	NULL
9	NULL
bases	NULL
long	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
has	NULL
been	NULL
compared	NULL
with	NULL
these	NULL
data	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
four	NULL
closely	NULL
related	NULL
motifs	NULL
,	NULL
ANANTTTCC	NULL
(	NULL
r	NULL
=	NULL
0.886	NULL
)	NULL
,	NULL
CANTTTCC	NULL
(	NULL
r	NULL
=	NULL
0.882	NULL
)	NULL
,	NULL
CNANNTTCC	NULL
(	NULL
¢	NULL
=	NULL
0.871	NULL
)	NULL
,	NULL
and	NULL
AGTTTCC	NULL
(	NULL
r	NULL
=	NULL
0.850	NULL
)	NULL
,	NULL
correlated	NULL
well	NULL
with	NULL
binding	NULL
strength	NULL
.	NULL

The	NULL
first	NULL
three	NULL
motifs	NULL
are	NULL
in	NULL
perfect	NULL
qualitative	NULL
agreement	NULL
with	NULL
the	NULL
data	NULL
,	NULL
meaning	NULL
that	NULL
each	NULL
competitor	NULL
fragment	NULL
containing	NULL
a	NULL
better	NULL
match	NULL
than	NULL
another	NULL
also	NULL
has	NULL
a	NULL
higher	NULL
or	NULL
equal	NULL
competitor	NULL
efficiency	NULL
.	NULL

The	NULL
``	NULL
best	NULL
'	NULL
motif	NULL
,	NULL
ANANTTTCC	NULL
,	NULL
has	NULL
been	NULL
used	NULL
to	NULL
indicate	NULL
putative	NULL
binding	NULL
sites	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
but	NULL
,	NULL
with	NULL
very	NULL
few	NULL
exceptions	NULL
,	NULL
all	NULL
four	NULL
variants	NULL
map	NULL
to	NULL
the	NULL
same	NULL
locations	NULL
in	NULL
5222	NULL
LATTION	NULL
ET	NULL
AL	NULL
.	NULL

MUTATED	NULL
BASE	NULL
_	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

MUTATED	NULL
BASE	NULL
35	NULL
40	NULL
45	NULL
0	NULL
45	NULL
$	NULL
T	NULL
G	NULL
G	NULL
G	NULL
G	NULL
A	NULL
C	NULL
T	NULL
Tf	NULL
T	NULL
¢	NULL
C	NULL
a	NULL
ST	NULL
G	NULL
G	NULL
G	NULL
G	NULL
A	NULL
C	NULL
T	NULL
T	NULL
C	NULL
A-COMPET	NULL
:	NULL
ys	NULL
w	NULL
C	NULL
)	NULL
OT-T	NULL
T	NULL
T	NULL
C	NULL
G	NULL
G	NULL
G	NULL
G	NULL
A	NULL
A	NULL
t	NULL
ys	NULL
%	NULL
C	NULL
I	NULL
T	NULL
6	NULL
G	NULL
a	NULL
G	NULL
@	NULL
A	NULL
A	NULL
C	NULL
Pc	NULL
60	NULL
|	NULL
|	NULL
|	NULL
|	NULL
pc	NULL
60	NULL
L_~	NULL
``	NULL
!	NULL

|	NULL
W	NULL
|	NULL
+	NULL
TRYPS	NULL
NP-TCpy	NULL
‘	NULL
.	NULL

in	NULL
“	NULL
?	NULL

!	NULL

|	NULL
|	NULL
|	NULL
1	NULL
@	NULL
@	NULL
»	NULL
-	NULL
®©IBRHHR	NULL
-	NULL
)	NULL
<	NULL
1	NULL
NF-KB	NULL
tm	NULL
lik	NULL
;	NULL
|	NULL
|	NULL
I	NULL
``	NULL
me	NULL
[	NULL
-il	NULL
Rw	NULL
i	NULL
#	NULL
e	NULL
|	NULL
e	NULL
-	NULL
|	NULL
ro	NULL
so	NULL
PC	NULL
60	NULL
%	NULL
+1L4	NULL
__|	NULL
+1L41	NULL
f	NULL
ays	NULL
+TRYPS	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Fine	NULL
specificities	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
PC6O	NULL
cells	NULL
,	NULL
cultured	NULL
in	NULL
normal	NULL
medium	NULL
or	NULL
treated	NULL
with	NULL
IL-1	NULL
,	NULL
were	NULL
used	NULL
undigested	NULL
or	NULL
after	NULL
treatment	NULL
with	NULL
trypsin	NULL
(	NULL
TRYPS	NULL
)	NULL
.	NULL

They	NULL
were	NULL
incubated	NULL
with	NULL
TC-II	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
45	NULL
M	NULL
excess	NULL
of	NULL
unlabelled	NULL
competitor	NULL
(	NULL
COMPET	NULL
)	NULL
.	NULL

Competing	NULL
DNA	NULL
was	NULL
unrelated	NULL
(	NULL
NS	NULL
)	NULL
or	NULL
contained	NULL
TC-II	NULL
motifs	NULL
with	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
indicated	NULL
position	NULL
(	NULL
position	NULL
34	NULL
corresponds	NULL
to	NULL
nt	NULL
234	NULL
in	NULL
the	NULL
SV40	NULL
enhancer	NULL
)	NULL
.	NULL

Competitor	NULL
*	NULL
combines	NULL
mutations	NULL
in	NULL
positions	NULL
234	NULL
(	NULL
T	NULL
-	NULL
>	NULL
A	NULL
)	NULL
and	NULL
246	NULL
(	NULL
A	NULL
-	NULL
>	NULL
G	NULL
)	NULL
.	NULL

«	NULL
1	NULL
,	NULL
major	NULL
trypsin	NULL
fragment	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
Tl	NULL
and	NULL
T2	NULL
,	NULL
major	NULL
trypsin	NULL
fragments	NULL
of	NULL
NP-TCy	NULL
.	NULL

the	NULL
competitor	NULL
fragments	NULL
.	NULL

Good	NULL
matches	NULL
to	NULL
all	NULL
four	NULL
motifs	NULL
are	NULL
also	NULL
found	NULL
in	NULL
the	NULL
three	NULL
NP-TC	NULL
,	NULL
,	NULL
binding	NULL
sites	NULL
detected	NULL
by	NULL
footprinting	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
and	NULL
in	NULL
the	NULL
GTIIc	NULL
+	NULL
GTI	NULL
segment	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

This	NULL
constitutes	NULL
independent	NULL
confirmation	NULL
of	NULL
the	NULL
NP-TC	NULL
,	NULL
,	NULL
consensus	NULL
binding	NULL
site	NULL
found	NULL
by	NULL
CONSCOR	NULL
.	NULL

NP-TC	NULL
;	NULL
,	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

Previous	NULL
transfection	NULL
experiments	NULL
had	NULL
shown	NULL
that	NULL
the	NULL
tetramerized	NULL
TC-II	NULL
motif	NULL
in	NULL
pG1.TC-30	NULL
conferred	NULL
a	NULL
very	NULL
strong	NULL
and	NULL
rapid	NULL
IL-1	NULL
response	NULL
on	NULL
the	NULL
rabbit	NULL
B-globin	NULL
promoter	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Baseline	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
same	NULL
construct	NULL
was	NULL
also	NULL
much	NULL
stronger	NULL
than	NULL
those	NULL
of	NULL
constructs	NULL
containing	NULL
no	NULL
or	NULL
other	NULL
enhancer	NULL
elements	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
constitutive	NULL
activity	NULL
is	NULL
due	NULL
to	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
pG1.TC	NULL
point	NULL
mutant	NULL
in	NULL
transiently	NULL
transfected	NULL
PC6O	NULL
cells	NULL
.	NULL

For	NULL
each	NULL
pG1.TC	NULL
plasmid	NULL
,	NULL
we	NULL
compared	NULL
constitutive	NULL
expression	NULL
with	NULL
expression	NULL
after	NULL
IL-1	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
pG1	NULL
expression	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
IL-1	NULL
and	NULL
expression	NULL
of	NULL
all	NULL
other	NULL
plasmids	NULL
was	NULL
normalized	NULL
to	NULL
this	NULL
level	NULL
.	NULL

Figure	NULL
7B	NULL
shows	NULL
that	NULL
the	NULL
pGI.TC	NULL
plasmids	NULL
fall	NULL
into	NULL
two	NULL
groups	NULL
:	NULL
the	NULL
first	NULL
group	NULL
includes	NULL
pG1.TC-30	NULL
(	NULL
containing	NULL
the	NULL
wild-type	NULL
TC-II	NULL
motif	NULL
)	NULL
and	NULL
plasmids	NULL
with	NULL
mutations	NULL
in	NULL
nt	NULL
234	NULL
,	NULL
235	NULL
,	NULL
236	NULL
,	NULL
238	NULL
,	NULL
240	NULL
,	NULL
243	NULL
,	NULL
and	NULL
246	NULL
,	NULL
which	NULL
are	NULL
more	NULL
strongly	NULL
expressed	NULL
in	NULL
IL-1-treated	NULL
cells	NULL
.	NULL

This	NULL
reflects	NULL
,	NULL
pre-sumably	NULL
,	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

For	NULL
these	NULL
plasmids	NULL
,	NULL
it	NULL
is	NULL
impossible	NULL
to	NULL
decide	NULL
whether	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-1	NULL
is	NULL
due	NULL
to	NULL
NP-TC	NULL
;	NULL
,	NULL
or	NULL
a	NULL
low	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
nuclei	NULL
of	NULL
noninduced	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
plasmids	NULL
belong	NULL
ing	NULL
to	NULL
the	NULL
second	NULL
group	NULL
and	NULL
carrying	NULL
mutations	NULL
in	NULL
nt	NULL
237	NULL
,	NULL
239	NULL
,	NULL
241	NULL
,	NULL
242	NULL
,	NULL
244	NULL
,	NULL
and	NULL
245	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
IL-1	NULL
treatment	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
plasmids	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
plasmids	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
their	NULL
TC-II	NULL
motif	NULL
to	NULL
compete	NULL
for	NULL
NP-TC	NULL
;	NULL
;	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
reveals	NULL
a	NULL
striking	NULL
correlation	NULL
:	NULL
the	NULL
mutation	NULL
of	NULL
nt	NULL
237	NULL
has	NULL
very	NULL
little	NULL
effect	NULL
on	NULL
NP-TC	NULL
;	NULL
,	NULL
binding	NULL
,	NULL
and	NULL
this	NULL
TC-II	NULL
variant	NULL
has	NULL
a	NULL
10-fold	NULL
constitutive	NULL
enhancer	NULL
activity	NULL
.	NULL

The	NULL
mutation	NULL
in	NULL
nt	NULL
239	NULL
reduces	NULL
NP-TC	NULL
;	NULL
,	NULL
binding	NULL
and	NULL
enhancer	NULL
activities	NULL
partially	NULL
.	NULL

Mutations	NULL
in	NULL
nt	NULL
241	NULL
and	NULL
245	NULL
reduce	NULL
both	NULL
binding	NULL
and	NULL
enhanson	NULL
activities	NULL
further	NULL
,	NULL
while	NULL
alterations	NULL
in	NULL
nt	NULL
242	NULL
and	NULL
244	NULL
diminish	NULL
both	NULL
almost	NULL
to	NULL
background	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
in	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

By	NULL
plotting	NULL
the	NULL
competitor	NULL
efficiency	NULL
of	NULL
the	NULL
IL-l-unresponsive	NULL
TC-II	NULL
variants	NULL
against	NULL
the	NULL
logarithm	NULL
of	NULL
their	NULL
transcriptional	NULL
activity	NULL
,	NULL
we	NULL
obtained	NULL
a	NULL
correlation	NULL
value	NULL
of	NULL
0.94	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

While	NULL
we	NULL
have	NULL
no	NULL
specific	NULL
explanation	NULL
for	NULL
the	NULL
linear	NULL
relationship	NULL
between	NULL
the	NULL
logarithm	NULL
of	NULL
transcriptional	NULL
activity	NULL
and	NULL
binding	NULL
activity	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
NP-TC	NULL
;	NULL
,	NULL
is	NULL
responsible	NULL
for	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
constitutive	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
TC-II	NULL
motif	NULL
.	NULL

NP-TC	NULL
;	NULL
;	NULL
differs	NULL
from	NULL
Rel-like	NULL
proteins	NULL
.	NULL

Both	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
(	NULL
p50	NULL
and	NULL
p65	NULL
)	NULL
belong	NULL
to	NULL
the	NULL
re/	NULL
proto-oncogene	NULL
family	NULL
(	NULL
13	NULL
,	NULL
20	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Proteins	NULL
belonging	NULL
to	NULL
this	NULL
family	NULL
can	NULL
dimerize	NULL
with	NULL
each	NULL
other	NULL
.	NULL

Our	NULL
previous	NULL
observations	NULL
that	NULL
NP-TC	NULL
;	NULL
,	NULL
had	NULL
a	NULL
binding	NULL
specificity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
NF-	NULL
<	NULL
B	NULL
led	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
NP-TC	NULL
;	NULL
;	NULL
was	NULL
related	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
experi-	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
A	NULL
DNase	NULL
I	NULL
DMS	NULL
NP	NULL
:	NULL
TCHy	NULL
(	NULL
:	NULL
o	NULL
>	NULL
2	NULL
4	NULL
2	NULL
4	NULL
-	NULL
2	NULL
4	NULL
COMPETITOR	NULL
:	NULL
wt	NULL
wt	NULL
284	NULL
2863	NULL
270	NULL
268	NULL
267	NULL
o	NULL
R	NULL
ai	NULL
LJ	NULL
TTcrteaceclecaAAAcAAclcaccteTecaatcTcT	NULL
1__	NULL
m	NULL
S	NULL
I	NULL
F	NULL
I	NULL
Le	NULL
nL	NULL
__	NULL
_j	NULL
site	NULL
II	NULL
Co	NULL
--	NULL
anis	NULL
d	NULL
site	NULL
I	NULL
o	NULL
au	NULL
245	NULL
244	NULL
m	NULL
3	NULL
a	NULL
GTCAGTTAGGGTGTGGAAAGTCCCCAG	NULL
P	NULL
cas	NULL
TC	NULL
-	NULL
11	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

DNase	NULL
I	NULL
and	NULL
DMS	NULL
footprints	NULL
on	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
End-labelled	NULL
DNA	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
heparin-fractionated	NULL
NP-TC	NULL
;	NULL
,	NULL
from	NULL
ELA	NULL
cells	NULL
and	NULL
treated	NULL
with	NULL
DNase	NULL
I	NULL
or	NULL
DMS	NULL
and	NULL
piperidine	NULL
.	NULL

Open	NULL
boxes	NULL
indicate	NULL
protected	NULL
regions	NULL
;	NULL
limits	NULL
are	NULL
given	NULL
.	NULL

wt	NULL
,	NULL
presence	NULL
of	NULL
unlabelled	NULL
TC-II	NULL
wild-type	NULL
sequence	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
results	NULL
.	NULL

Symbols	NULL
:	NULL
O	NULL
,	NULL
G	NULL
's	NULL
protected	NULL
against	NULL
methylation	NULL
by	NULL
DMS	NULL
;	NULL
®	NULL
,	NULL
hypermethylated	NULL
G	NULL
's	NULL
.	NULL

DNase	NULL
I	NULL
footprints	NULL
are	NULL
underlined	NULL
.	NULL

Boxes	NULL
indicate	NULL
the	NULL
occurrence	NULL
of	NULL
the	NULL
NP-TC	NULL
;	NULL
,	NULL
binding	NULL
motif	NULL
found	NULL
by	NULL
the	NULL
CONSCOR	NULL
algorithm	NULL
(	NULL
see	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

TC-II	NULL
,	NULL
site	NULL
I	NULL
,	NULL
and	NULL
site	NULL
II	NULL
indicate	NULL
the	NULL
repeat	NULL
of	NULL
the	NULL
motif	NULL
G	NULL
(	NULL
T/	NULL
C	NULL
)	NULL
GGAA	NULL
(	NULL
T/A	NULL
)	NULL
G.	NULL
ments	NULL
described	NULL
above	NULL
show	NULL
that	NULL
NP-TC	NULL
;	NULL
;	NULL
is	NULL
not	NULL
identical	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
they	NULL
do	NULL
not	NULL
exclude	NULL
a	NULL
close	NULL
relationship	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
Rel	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
NP-TC	NULL
,	NULL
;	NULL
could	NULL
interact	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
cytoplasmic	NULL
inhibitor	NULL
IB	NULL
,	NULL
which	NULL
associates	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
inhibits	NULL
its	NULL
binding	NULL
activity	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Purified	NULL
IxBa	NULL
(	NULL
40	NULL
pg	NULL
)	NULL
(	NULL
55	NULL
)	NULL
could	NULL
completely	NULL
abolish	NULL
NF-	NULL
«	NULL
xB	NULL
binding	NULL
activity	NULL
in	NULL
extracts	NULL
from	NULL
PC6O	NULL
and	NULL
70Z/3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
but	NULL
failed	NULL
to	NULL
inhibit	NULL
or	NULL
modify	NULL
NP-TC	NULL
;	NULL
,	NULL
binding	NULL
activity	NULL
.	NULL

We	NULL
also	NULL
checked	NULL
whether	NULL
anti-NF-	NULL
«	NULL
B	NULL
or	NULL
anti-Rel	NULL
antibodies	NULL
cross-reacted	NULL
with	NULL
NP-TC	NULL
;	NULL
,	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

While	NULL
an	NULL
antiserum	NULL
against	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
causes	NULL
partial	NULL
disappearance	NULL
and	NULL
supershifting	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
formed	NULL
by	NULL
extracts	NULL
from	NULL
TNF-treated	NULL
Jurkat	NULL
cells	NULL
,	NULL
it	NULL
does	NULL
not	NULL
modify	NULL
the	NULL
patterns	NULL
of	NULL
the	NULL
complexes	NULL
due	NULL
to	NULL
NP-TC	NULL
;	NULL
,	NULL
or	NULL
'sowouou	NULL
ay	NULL
}	NULL
JO	NULL
suna	NULL
)	NULL
ut	NULL
passoidxa	NULL
st	NULL
ssaoxe	NULL
1gjour	NULL
ououreno	NULL
)	NULL
[	NULL
J-O	NULL
,	NULL
poreinu	NULL
pue	NULL
'1ooueyuo	NULL
(	NULL
pAS	NULL
oli	NULL
wou	NULL
}	NULL
paauiop	NULL
souanbas	NULL
ay	NULL
;	NULL
Jo	NULL
s13p10q	NULL
ay	NULL
}	NULL
ajeoiput	NULL
souanbas	NULL
yards	NULL
anoge	NULL
sitaquinu	NULL
aJ	NULL
,	NULL
,	NULL
TRANSCRIPTION	NULL
FACTOR	NULL
NP-TC	NULL
,	NULL
,	NULL
(	NULL
IM	NULL
II-D.L	NULL
)	NULL
OCOL	NULL
agqoid	NULL
II-OL	NULL
Joouryua	NULL
OpAS	NULL
(	NULL
66	NULL
)	NULL
4x9	NULL
(	NULL
86¢-	NULL
91	NULL
805-	NULL
19	NULL
)	NULL
(	NULL
Tp	NULL
)	NULL
»	NULL
ANLW	NULL
01	NULL
999-	NULL
194	NULL
)	NULL
(	NULL
Tp	NULL
)	NULL
»	NULL
ANLW	NULL
(	NULL
S0z-	NULL
91	NULL
€E€2-	NULL
314	NULL
)	NULL
(	NULL
0€	NULL
)	NULL
(	NULL
€97	NULL
01	NULL
Tsz	NULL
14	NULL
)	NULL
(	NULL
pg	NULL
)	NULL
»	NULL
3jw	NULL
D|JJLLLOVBB|DDOY	NULL
LODLDODDLLLOODDODDOVOVVY	NULL
DVDLODDBVDDOOLLVYDLODDNLODYDLOD	NULL
LYD	NULL
-	NULL
<	NULL
**	NULL
*	NULL
DVDODY|J.LLLOYVDOD|DOLOYDOOOL	NULL
*suontsod	NULL
apnosjonu	NULL
ay	NULL
}	NULL
arojeq	NULL
pue	NULL
saureu	NULL
aus	NULL
$	NULL
ay	NULL
)	NULL
sope	NULL
Ajorespawnuy	NULL
sasayjuared	NULL
uf	NULL
are	NULL
siaquinu	NULL
,	NULL
,	NULL
'pourpopun	NULL
are	NULL
says	NULL
ga	NULL
umoiry	NULL
;	NULL
'saxoq	NULL
se	NULL
umoys	NULL
ale	NULL
soeJpjog	NULL
4q	NULL
umoys	NULL
sayojeur	NULL
gz	NULL
)	NULL
SJHOW	NULL
DOLLLNVNV	NULL
»	NULL
DVILOLLDLYVDDVOVILOLLOVILOYILOLLOLYDDYOVILDLY	NULL
§6-	NULL
&	NULL
**	NULL
*DODDOVOL	NULL
DVDDILDLILO	NULL
[	NULL
VJ.LLLOYVOY|	NULL
DDLDODVDDODVILODDDDDOLYVDDOYOD|	NULL
DO.LOVYVII|LOLODLYDOVDOVILOLOYDOLODYVDOLOODLYOOL	NULL
0	NULL
0	NULL
w	NULL
o	NULL
-_	NULL
a	NULL
75,2	NULL
5	NULL
®	NULL
bo	NULL
2	NULL
&	NULL
3	NULL
*	NULL
I	NULL
to	NULL
O	NULL
Go	NULL
8	NULL
+	NULL
ta	NULL
<	NULL
Poa	NULL
ﬁg	NULL
G	NULL
a	NULL
g	NULL
C	NULL
e	NULL
2	NULL
E	NULL
C	NULL
bel	NULL
C	NULL
a	NULL
a	NULL
®	NULL
9	NULL
&	NULL
5	NULL
a	NULL
5	NULL
a	NULL
[	NULL
@	NULL
]	NULL
&	NULL
(	NULL
-p	NULL
)	NULL
g	NULL
&	NULL
fact	NULL
a	NULL
HJ	NULL
[	NULL
#	NULL
+	NULL
C	NULL
&	NULL
c	NULL
(	NULL
e	NULL
]	NULL
sa	NULL
5223	NULL
suan	NULL
{	NULL
,	NULL
¢-,5	NULL
)	NULL
sousnbag	NULL
Ananse	NULL
Suipurq	NULL
HOW	NULL
OO	NULL
LLLNVNY	NULL
J0	NULL
°	NULL
?	NULL

5224	NULL
LATTION	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro	NULL
.	NULL

A	NULL
-	NULL
Plasmid	NULL
35	NULL
36	NULL
37	NULL
38	NULL
39	NULL
40	NULL
41	NULL
42	NULL
44	NULL
45	NULL
46	NULL
``	NULL
-..	NULL
®	NULL
&	NULL
--	NULL
--	NULL
-	NULL
3/0.2	NULL
oren	NULL
II	NULL
24	NULL
alll	NULL
pG1/pGBAcBGID	NULL
pG1i	NULL
I	NULL
vu	NULL
tar	NULL
)	NULL
ted	NULL
mat	NULL
tt	NULL
cau	NULL
)	NULL
W	NULL
)	NULL
Soul	NULL
haud	NULL
>	NULL
)	NULL
Seid	NULL
wes	NULL
\	NULL
*	NULL
i	NULL
304	NULL
mRNA	NULL
|	NULL
_	NULL
|	NULL
|	NULL
Signals	NULL
[	NULL
pGBAcBGID	NULL
l	NULL
|	NULL
E	NULL
weet	NULL
|	NULL
-	NULL
221/0	NULL
|	NULL
Losee	NULL
,	NULL
__	NULL
...	NULL
P	NULL
T	NULL
``	NULL
s	NULL
es	NULL
I	NULL
Controls	NULL
-	NULL
M	NULL
Plasmid	NULL
:	NULL
39	NULL
40	NULL
41	NULL
42	NULL
43	NULL
44	NULL
45	NULL
46	NULL
43	NULL
(	NULL
)	NULL
onl	NULL
a	NULL
edith	NULL
IL~1	NULL
1	NULL
W	NULL
G1/pGBAcBGID	NULL
_L	NULL
on-	NULL
]	NULL
2	NULL
.	NULL

P	NULL
P	NULL
P	NULL
a	NULL
``	NULL
0.2	NULL
[	NULL
-	NULL
p61	NULL
whee	NULL
wil	NULL
mRNA	NULL
Signals	NULL
|	NULL
|	NULL
pGBAcBGID	NULL
he-	NULL
wath	NULL
we	NULL
wae	NULL
ws	NULL
|	NULL
|	NULL
3	NULL
10000	NULL
C	NULL
37m	NULL
34	NULL
C	NULL
E	NULL
R	NULL
,	NULL
;	NULL
$	NULL
w	NULL
40	NULL
ao	NULL
E	NULL
``	NULL
00	NULL
38	NULL
40	NULL
7	NULL
he	NULL
!	NULL

2	NULL
é	NULL
H	NULL
,	NULL
00	NULL
a	NULL
€	NULL
m45	NULL
I	NULL
M4	NULL
M37	NULL
ti	NULL
I4	NULL
)	NULL
m	NULL
3	NULL
10	NULL
M45	NULL
44	NULL
m4	NULL
1	NULL
c	NULL
44	NULL
0.0	NULL
0.1	NULL
0.2	NULL
0.3	NULL
0.4	NULL
0.5	NULL
0.6	NULL
if	NULL
”	NULL
:	NULL
1	NULL
/ng	NULL
competitor	NULL
required	NULL
1	NULL
7	NULL
for	NULL
50	NULL
%	NULL
inhibition	NULL
of	NULL
NP-TC	NULL
,	NULL
,	NULL
binding	NULL
10	NULL
100	NULL
Non-Induced	NULL
Expression	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Relative	NULL
enhancer	NULL
activity	NULL
of	NULL
TC-II	NULL
wild-type	NULL
or	NULL
mutant	NULL
tetramers	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Results	NULL
from	NULL
a	NULL
single	NULL
transfection	NULL
experiment	NULL
.	NULL

Each	NULL
lane	NULL
shows	NULL
the	NULL
mRNA-derived	NULL
polymerase	NULL
chain	NULL
reaction	NULL
fragments	NULL
from	NULL
PC6O	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
the	NULL
reference	NULL
plasmid	NULL
pGBAcBGD	NULL
and	NULL
a	NULL
pG1	NULL
plasmid	NULL
.	NULL

pG1L.TC	NULL
plasmids	NULL
are	NULL
identified	NULL
by	NULL
the	NULL
position	NULL
of	NULL
the	NULL
mutated	NULL
TC-HI	NULL
nucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

pG1.TC-30	NULL
(	NULL
w	NULL
)	NULL
contains	NULL
the	NULL
nonmutated	NULL
TC-II	NULL
motif	NULL
;	NULL
pG1	NULL
contains	NULL
no	NULL
enhancer	NULL
motifs	NULL
.	NULL

M	NULL
,	NULL
size	NULL
markers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
different	NULL
plasmids	NULL
in	NULL
untreated	NULL
or	NULL
IL-l-treated	NULL
PC60	NULL
cells	NULL
.	NULL

For	NULL
each	NULL
sample	NULL
,	NULL
the	NULL
ratio	NULL
between	NULL
pG1L.TC	NULL
and	NULL
pGBAcBGD	NULL
mRNA	NULL
signals	NULL
is	NULL
measured	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Expression	NULL
values	NULL
standardized	NULL
in	NULL
this	NULL
way	NULL
are	NULL
normalized	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
enhancerless	NULL
plasmid	NULL
pG1	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Correlation	NULL
between	NULL
enhanson	NULL
activity	NULL
and	NULL
NP-TC	NULL
;	NULL
;	NULL
binding	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
cold	NULL
competitor	NULL
needed	NULL
to	NULL
inhibit	NULL
50	NULL
%	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
binding	NULL
was	NULL
determined	NULL
for	NULL
IL-l-unresponsive	NULL
TC-I1	NULL
mutants	NULL
.	NULL

The	NULL
correlation	NULL
between	NULL
NP-TC	NULL
;	NULL
;	NULL
binding	NULL
activities	NULL
and	NULL
constitutive	NULL
enhancer	NULL
activities	NULL
(	NULL
normalized	NULL
to	NULL
pG1	NULL
)	NULL
is	NULL
0.942.	NULL
its	NULL
digested	NULL
fragments	NULL
.	NULL

Likewise	NULL
,	NULL
polyclonal	NULL
antibodies	NULL
raised	NULL
against	NULL
a	NULL
segment	NULL
of	NULL
v-Rel	NULL
and	NULL
also	NULL
recognizing	NULL
mammalian	NULL
c-Rel	NULL
(	NULL
45	NULL
)	NULL
partially	NULL
upshifted	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
well	NULL
as	NULL
x1	NULL
complexes	NULL
but	NULL
not	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
or	NULL
Tl	NULL
or	NULL
T2	NULL
complexes	NULL
.	NULL

A	NULL
characteristic	NULL
feature	NULL
of	NULL
most	NULL
so	NULL
far	NULL
described	NULL
Rel-related	NULL
proteins	NULL
is	NULL
their	NULL
localization	NULL
as	NULL
an	NULL
inactive	NULL
complex	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
noninduced	NULL
cells	NULL
and	NULL
their	NULL
activation	NULL
and	NULL
translocation	NULL
into	NULL
the	NULL
nucleus	NULL
upon	NULL
appropriate	NULL
stimulation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
Rel	NULL
complexes	NULL
can	NULL
be	NULL
disrupted	NULL
and	NULL
binding	NULL
activity	NULL
can	NULL
be	NULL
revealed	NULL
by	NULL
treatment	NULL
with	NULL
dissoci-	NULL
ating	NULL
agents	NULL
such	NULL
as	NULL
DOC	NULL
.	NULL

DOC	NULL
treatment	NULL
of	NULL
cytosolic	NULL
extracts	NULL
from	NULL
PC6O0	NULL
cells	NULL
or	NULL
unstimulated	NULL
70Z7/3	NULL
or	NULL
HeLa	NULL
cells	NULL
whose	NULL
nuclei	NULL
contain	NULL
little	NULL
or	NULL
no	NULL
detectable	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
revealed	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
but	NULL
no	NULL
NP-TC	NULL
;	NULL
,	NULL
;	NULL
binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
NP-TC	NULL
,	NULL
,	NULL
-DNA	NULL
complexes	NULL
migrate	NULL
as	NULL
a	NULL
broad	NULL
band	NULL
.	NULL

This	NULL
heterogeneity	NULL
is	NULL
due	NULL
to	NULL
size	NULL
variation	NULL
,	NULL
as	NULL
it	NULL
can	NULL
be	NULL
partially	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
EXTRACT	NULL
:	NULL
-	NULL
PC6O	NULL
PC6O	NULL
+	NULL
IL-1	NULL
_	NULL
702	NULL
/	NULL
3	NULL
+	NULL
IL-1	NULL
r	NULL
+f	NULL
1	NULL
1	NULL
I	NULL
ATP	NULL
:	NULL
IB	NULL
:	NULL
-	NULL
MM	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
IxB	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NP-TCy	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
1	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
TC-II	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ATP	NULL
and/or	NULL
40	NULL
pg	NULL
of	NULL
IxBa	NULL
.	NULL

F	NULL
,	NULL
free	NULL
DNA	NULL
.	NULL

resolved	NULL
by	NULL
gel	NULL
filtration	NULL
chromatography	NULL
.	NULL

It	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
due	NULL
to	NULL
proteolytic	NULL
degradation	NULL
,	NULL
as	NULL
it	NULL
is	NULL
not	NULL
reduced	NULL
by	NULL
a	NULL
range	NULL
of	NULL
protease	NULL
inhibitors	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
limited	NULL
trypsin	NULL
digestion	NULL
of	NULL
different	NULL
chromatographic	NULL
fractions	NULL
of	NULL
NP-TC	NULL
;	NULL
;	NULL
yields	NULL
the	NULL
same	NULL
well-defined	NULL
DNA-binding	NULL
fragments	NULL
with	NULL
identical	NULL
fine	NULL
specificities	NULL
suggests	NULL
either	NULL
that	NULL
NP-TC	NULL
,	NULL
;	NULL
is	NULL
a	NULL
family	NULL
of	NULL
related	NULL
proteins	NULL
with	NULL
the	NULL
same	NULL
DNA-binding	NULL
domain	NULL
or	NULL
that	NULL
it	NULL
consists	NULL
of	NULL
different	NULL
oligomeric	NULL
complexes	NULL
with	NULL
the	NULL
same	NULL
DNA-binding	NULL
subunit	NULL
.	NULL

So	NULL
far	NULL
,	NULL
our	NULL
attempts	NULL
to	NULL
dissociate	NULL
such	NULL
complexes	NULL
without	NULL
destroying	NULL
the	NULL
DNA-binding	NULL
activity	NULL
have	NULL
been	NULL
unsuccessful	NULL
.	NULL

NP-TC	NULL
;	NULL
,	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

is	NULL
a	NULL
constitutive	NULL
nuclear	NULL
protein	NULL
that	NULL
specifically	NULL
recognizes	NULL
the	NULL
TC-II	NULL
motif	NULL
in	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

TC-II	NULL
is	NULL
a	NULL
protoenhancer	NULL
that	NULL
strongly	NULL
responds	NULL
to	NULL
NF-kB	NULL
.	NULL

This	NULL
has	NULL
complicated	NULL
analysis	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
function	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
,	NULL
.	NULL

But	NULL
the	NULL
very	NULL
close	NULL
correlation	NULL
between	NULL
NP-TC	NULL
,	NULL
;	NULL
binding	NULL
capacity	NULL
and	NULL
enhanson	NULL
activity	NULL
of	NULL
those	NULL
TC-II	NULL
mutants	NULL
which	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
NF-KB	NULL
indicates	NULL
that	NULL
NP-TC	NULL
,	NULL
,	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
strongest	NULL
IL-1-unresponsive	NULL
plasmid	NULL
,	NULL
pG1.TC-37	NULL
,	NULL
is	NULL
much	NULL
weaker	NULL
than	NULL
the	NULL
constitutive	NULL
activity	NULL
of	NULL
pG1.TC-30	NULL
containing	NULL
the	NULL
wild-type	NULL
TC-II	NULL
motif	NULL
,	NULL
suggesting	NULL
that	NULL
NP-TC	NULL
,	NULL
,	NULL
is	NULL
a	NULL
weaker	NULL
transcriptional	NULL
activator	NULL
than	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

NP-TC	NULL
;	NULL
,	NULL
,	NULL
may	NULL
be	NULL
a	NULL
marker	NULL
of	NULL
early	NULL
lymphoid	NULL
differentiation	NULL
.	NULL

NP-TC	NULL
,	NULL
;	NULL
activity	NULL
is	NULL
strongest	NULL
in	NULL
nuclei	NULL
of	NULL
T-	NULL
and	NULL
pre-T-cell	NULL
lines	NULL
and	NULL
normal	NULL
thymic	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
present	NULL
also	NULL
in	NULL
most	NULL
B-	NULL
and	NULL
pre-B-cell	NULL
lines	NULL
and	NULL
splenic	NULL
B	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
a	NULL
primitive	NULL
hemopoetic	NULL
precursor	NULL
line	NULL
(	NULL
K562	NULL
)	NULL
,	NULL
but	NULL
was	NULL
undetectable	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
nonhemopoietic	NULL
cell	NULL
lines	NULL
or	NULL
tissues	NULL
.	NULL

This	NULL
tissue	NULL
distribution	NULL
suggests	NULL
that	NULL
NP-TC	NULL
;	NULL
,	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
lymphocyte	NULL
differentiation	NULL
.	NULL

NP-TC	NULL
,	NULL
,	NULL
is	NULL
not	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
Rel	NULL
proteins	NULL
.	NULL

Preliminary	NULL
characterization	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
had	NULL
indicated	NULL
similarity	NULL
of	NULL
its	NULL
DNA-binding	NULL
specificity	NULL
to	NULL
that	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
NP-TC	NULL
;	NULL
,	NULL
is	NULL
not	NULL
related	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
another	NULL
member	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
.	NULL

Five	NULL
lines	NULL
of	NULL
evidence	NULL
argue	NULL
specifically	NULL
against	NULL
a	NULL
relationship	NULL
of	NULL
NP-TC	NULL
;	NULL
;	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Limited	NULL
trypsin	NULL
digestion	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
yields	NULL
different	NULL
DNA-binding	NULL
fragments	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Both	NULL
proteins	NULL
elute	NULL
at	NULL
different	NULL
ionic	NULL
strengths	NULL
from	NULL
a	NULL
heparin	NULL
TRANSCRIPTION	NULL
FACTOR	NULL
NP-TC	NULL
,	NULL
,	NULL
5225	NULL
column	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
DNA	NULL
binding	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
can	NULL
not	NULL
be	NULL
inhibited	NULL
by	NULL
IxBa	NULL
,	NULL
the	NULL
protein	NULL
forming	NULL
an	NULL
inactive	NULL
complex	NULL
with	NULL
NF-kB	NULL
by	NULL
binding	NULL
to	NULL
its	NULL
p65	NULL
subunit	NULL
.	NULL

(	NULL
iv	NULL
)	NULL
Antibodies	NULL
against	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-kB	NULL
do	NULL
not	NULL
react	NULL
with	NULL
(	NULL
v	NULL
)	NULL
The	NULL
fine	NULL
specificities	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
show	NULL
clear	NULL
differences	NULL
despite	NULL
an	NULL
overall	NULL
similarity	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
capacity	NULL
of	NULL
other	NULL
TC-II-related	NULL
sequences	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
;	NULL
and	NULL
NF-KB	NULL
to	NULL
the	NULL
TC-II	NULL
motif	NULL
has	NULL
confirmed	NULL
this	NULL
picture	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Both	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
(	NULL
p50	NULL
and	NULL
p65	NULL
)	NULL
belong	NULL
to	NULL
the	NULL
re	NULL
!	NULL

proto-oncogene	NULL
family	NULL
.	NULL

One	NULL
of	NULL
the	NULL
characteristics	NULL
of	NULL
most	NULL
Rel-related	NULL
proteins	NULL
is	NULL
their	NULL
presence	NULL
as	NULL
inactive	NULL
precursors	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
their	NULL
translocation	NULL
into	NULL
the	NULL
nucleus	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NP-TC	NULL
;	NULL
,	NULL
is	NULL
either	NULL
constitutively	NULL
active	NULL
(	NULL
in	NULL
most	NULL
lymphoid	NULL
cells	NULL
and	NULL
cell	NULL
lines	NULL
)	NULL
or	NULL
undetectable	NULL
in	NULL
nucleus	NULL
or	NULL
cytoplasm	NULL
,	NULL
even	NULL
after	NULL
treatment	NULL
with	NULL
dissociating	NULL
agents	NULL
which	NULL
reveal	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
cytoplasmic	NULL
Rel	NULL
proteins	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Evidence	NULL
against	NULL
a	NULL
close	NULL
relationship	NULL
between	NULL
NP-TC	NULL
;	NULL
and	NULL
Re	NULL
!	NULL

is	NULL
also	NULL
provided	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
,	NULL
unlike	NULL
NP-TCJ	NULL
,	NULL
,	NULL
Rel	NULL
protein	NULL
p75	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
B	NULL
motif	NULL
in	NULL
the	NULL
H-2K	NULL
gene	NULL
(	NULL
28	NULL
)	NULL
and	NULL
that	NULL
anti-chicken	NULL
Rel	NULL
antibodies	NULL
that	NULL
cross-react	NULL
with	NULL
mammalian	NULL
Rel	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
do	NULL
not	NULL
affect	NULL
NP-TC	NULL
;	NULL
;	NULL
band	NULL
shifts	NULL
.	NULL

Derivation	NULL
of	NULL
a	NULL
tentative	NULL
consensus	NULL
sequence	NULL
for	NULL
NP-TC	NULL
,	NULL
,	NULL
.	NULL

A	NULL
novel	NULL
algorithm	NULL
,	NULL
CONSCOR	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
has	NULL
been	NULL
used	NULL
to	NULL
derive	NULL
a	NULL
consensus	NULL
recognition	NULL
sequence	NULL
for	NULL
NP-TC	NULL
;	NULL
,	NULL
which	NULL
is	NULL
in	NULL
perfect	NULL
qualitative	NULL
agreement	NULL
with	NULL
the	NULL
experimental	NULL
evidence	NULL
.	NULL

The	NULL
advantage	NULL
of	NULL
CONSCOR	NULL
over	NULL
other	NULL
techniques	NULL
based	NULL
on	NULL
alignment	NULL
of	NULL
putative	NULL
protein	NULL
binding	NULL
regions	NULL
(	NULL
23	NULL
,	NULL
48	NULL
)	NULL
is	NULL
that	NULL
it	NULL
uses	NULL
``	NULL
negative	NULL
results	NULL
``	NULL
to	NULL
penalize	NULL
motifs	NULL
that	NULL
occur	NULL
on	NULL
sequences	NULL
which	NULL
do	NULL
not	NULL
bind	NULL
the	NULL
protein	NULL
.	NULL

Since	NULL
the	NULL
NP-TC	NULL
,	NULL
,	NULL
recognition	NULL
motif	NULL
was	NULL
derived	NULL
from	NULL
data	NULL
with	NULL
relatively	NULL
few	NULL
competitor	NULL
fragments	NULL
,	NULL
the	NULL
candidate	NULL
consensus	NULL
sequences	NULL
had	NULL
to	NULL
satisfy	NULL
correspondingly	NULL
few	NULL
constraints	NULL
.	NULL

However	NULL
,	NULL
the	NULL
results	NULL
of	NULL
the	NULL
CONSCOR	NULL
analysis	NULL
are	NULL
confirmed	NULL
by	NULL
the	NULL
footprinting	NULL
experiments	NULL
,	NULL
which	NULL
identify	NULL
completely	NULL
independently	NULL
two	NULL
binding	NULL
sites	NULL
that	NULL
contain	NULL
good	NULL
matches	NULL
with	NULL
the	NULL
highest-scoring	NULL
NP-TC	NULL
,	NULL
recognition	NULL
motif	NULL
determined	NULL
by	NULL
CONSCOR	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Further	NULL
experiments	NULL
are	NULL
necessary	NULL
to	NULL
discriminate	NULL
among	NULL
the	NULL
four	NULL
variants	NULL
with	NULL
virtually	NULL
identical	NULL
scores	NULL
.	NULL

NP-TC	NULL
;	NULL
;	NULL
differs	NULL
from	NULL
other	NULL
previously	NULL
described	NULL
lymphocyte-specific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Several	NULL
other	NULL
nuclear	NULL
proteins	NULL
that	NULL
recognize	NULL
the	NULL
TC-II	NULL
motif	NULL
or	NULL
related	NULL
sequences	NULL
have	NULL
been	NULL
described	NULL
,	NULL
but	NULL
each	NULL
of	NULL
them	NULL
has	NULL
characteristics	NULL
that	NULL
distinguish	NULL
it	NULL
from	NULL
NP-TC-II	NULL
.	NULL

The	NULL
TC-II	NULL
sequence	NULL
overlaps	NULL
with	NULL
the	NULL
AP2	NULL
,	NULL
AP3	NULL
,	NULL
and	NULL
EBP1	NULL
motifs	NULL
,	NULL
but	NULL
some	NULL
of	NULL
the	NULL
mutations	NULL
that	NULL
affect	NULL
binding	NULL
of	NULL
NP-TC	NULL
,	NULL
,	NULL
are	NULL
located	NULL
outside	NULL
the	NULL
binding	NULL
sites	NULL
of	NULL
these	NULL
factors	NULL
(	NULL
5	NULL
,	NULL
15	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Further-more	NULL
,	NULL
these	NULL
proteins	NULL
are	NULL
present	NULL
in	NULL
unstimulated	NULL
HeLa	NULL
cells	NULL
.	NULL

Some	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
(	NULL
EBP20	NULL
[	NULL
16	NULL
]	NULL
,	NULL
AGIE-BPI	NULL
[	NULL
37	NULL
]	NULL
,	NULL
AGP/EBP	NULL
[	NULL
6	NULL
]	NULL
,	NULL
H	NULL
[	NULL
4	NULL
]	NULL
,	NULL
IL-6DBP	NULL
[	NULL
35	NULL
]	NULL
,	NULL
and	NULL
NF-IL6	NULL
[	NULL
42	NULL
]	NULL
)	NULL
bind	NULL
«	NULL
B-like	NULL
sequences	NULL
.	NULL

However	NULL
,	NULL
these	NULL
proteins	NULL
have	NULL
been	NULL
found	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
,	NULL
and	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
NP-TC	NULL
,	NULL
,	NULL
most	NULL
of	NULL
them	NULL
are	NULL
heat	NULL
stable	NULL
.	NULL

Another	NULL
C/EBP	NULL
factor	NULL
,	NULL
NF-M	NULL
,	NULL
is	NULL
present	NULL
in	NULL
various	NULL
hemopoietic	NULL
cells	NULL
belonging	NULL
to	NULL
the	NULL
myeloid	NULL
and	NULL
monocytic	NULL
lineages	NULL
,	NULL
whereas	NULL
its	NULL
activity	NULL
in	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
is	NULL
very	NULL
weak	NULL
(	NULL
47	NULL
)	NULL
.	NULL

MBP1	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
H2-K	NULL
``	NULL
<	NULL
B-like	NULL
sequence	NULL
(	NULL
3	NULL
)	NULL
,	NULL
was	NULL
cloned	NULL
from	NULL
a	NULL
B-cell	NULL
line	NULL
,	NULL
but	NULL
its	NULL
mRNA	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
present	NULL
only	NULL
at	NULL
a	NULL
very	NULL
low	NULL
level	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
ets-1	NULL
proto-oncogene	NULL
product	NULL
has	NULL
a	NULL
tissue	NULL
distribution	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
NP-TC	NULL
;	NULL
,	NULL
but	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
TC-II	NULL
motif	NULL
(	NULL
10a	NULL
)	NULL
.	NULL

LyF-1	NULL
binds	NULL
to	NULL
several	NULL
lymphocyte-specific	NULL
gene	NULL
promoters	NULL
but	NULL
is	NULL
present	NULL
in	NULL
HeLa	NULL
5226	NULL
LATTHION	NULL
ET	NULL
AL	NULL
.	NULL

and	NULL
not	NULL
in	NULL
the	NULL
BW5147	NULL
or	NULL
K562	NULL
cell	NULL
line	NULL
(	NULL
24	NULL
)	NULL
.	NULL

TCF-la	NULL
«	NULL
binds	NULL
to	NULL
related	NULL
sequences	NULL
in	NULL
promoters	NULL
of	NULL
several	NULL
genes	NULL
expressed	NULL
early	NULL
in	NULL
T-cell	NULL
development	NULL
.	NULL

But	NULL
it	NULL
is	NULL
not	NULL
found	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
including	NULL
Namalwa	NULL
cells	NULL
,	NULL
which	NULL
contain	NULL
large	NULL
amounts	NULL
of	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
NP-TC	NULL
;	NULL
;	NULL
is	NULL
most	NULL
likely	NULL
a	NULL
new	NULL
transcription	NULL
factor	NULL
that	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
lymphocyte	NULL
differentiation	NULL
.	NULL

To	NULL
determine	NULL
definitively	NULL
its	NULL
role	NULL
,	NULL
we	NULL
need	NULL
to	NULL
further	NULL
characterize	NULL
and	NULL
molecularly	NULL
clone	NULL
the	NULL
constituent	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
A.-L.L	NULL
.	NULL

and	NULL
E.E	NULL
.	NULL

have	NULL
made	NULL
equal	NULL
contributions	NULL
to	NULL
the	NULL
work	NULL
described	NULL
in	NULL
this	NULL
article	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Swiss	NULL
National	NULL
Science	NULL
Foundation	NULL
to	NULL
MN	NULL
.	NULL

We	NULL
thank	NULL
P.	NULL
Chambon	NULL
for	NULL
the	NULL
pG1.TC	NULL
plasmids	NULL
and	NULL
Anne	NULL
Wilson	NULL
,	NULL
Victor	NULL
Jongeneel	NULL
,	NULL
and	NULL
Stefan	NULL
Carrel	NULL
for	NULL
various	NULL
normal	NULL
cell	NULL
populations	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

Pierre	NULL
Dubied	NULL
and	NULL
Marcel	NULL
Allegrini	NULL
prepared	NULL
the	NULL
photos	NULL
and	NULL
figures	NULL
,	NULL
and	NULL
Claudine	NULL
Ravussin	NULL
helped	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Moira	NULL
Cockell	NULL
,	NULL
Anne	NULL
Wilson	NULL
,	NULL
and	NULL
Otto	NULL
Hagenbiichle	NULL
for	NULL
valuable	NULL
discussions	NULL
of	NULL
the	NULL
work	NULL
and	NULL
advice	NULL
concerning	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baeuerie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

2	NULL
.	NULL

Baeuerie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

3	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
,	NULL
K.	NULL
P.	NULL
LeClair	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
large	NULL
protein	NULL
containing	NULL
zinc	NULL
finger	NULL
domains	NULL
binds	NULL
to	NULL
related	NULL
sequence	NULL
elements	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
the	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
complex	NULL
and	NULL
kappa	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1406-1414	NULL
.	NULL

4	NULL
.	NULL

Brasier	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
D.	NULL
Ron	NULL
,	NULL
J.	NULL
E.	NULL
Tate	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
family	NULL
of	NULL
constitutive	NULL
C/EBP-like	NULL
DNA	NULL
binding	NULL
proteins	NULL
attenuate	NULL
the	NULL
IL-1a	NULL
induced	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
mediated	NULL
transactivation	NULL
of	NULL
the	NULL
angiotensinogen	NULL
gene	NULL
acute-phase	NULL
response	NULL
element	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:3933-3944	NULL
.	NULL

5	NULL
.	NULL

Bruder	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
P.	NULL
Hearing	NULL
.	NULL

1989	NULL
.	NULL

Nuclear	NULL
factor	NULL
EF-1A	NULL
binds	NULL
to	NULL
the	NULL
adenovirus	NULL
ElA	NULL
core	NULL
enhancer	NULL
element	NULL
and	NULL
to	NULL
other	NULL
transcriptional	NULL
control	NULL
regions	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:5143-5153	NULL
.	NULL

6	NULL
.	NULL

Chang	NULL
,	NULL
C.-J	NULL
.	NULL

,	NULL
T.-T.	NULL
Chen	NULL
,	NULL
H.-Y	NULL
.	NULL

Lei	NULL
,	NULL
D.-S.	NULL
Chen	NULL
,	NULL
and	NULL
S.-C.	NULL
Lee	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
,	NULL
AGP/EBP	NULL
,	NULL
that	NULL
belongs	NULL
to	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6642-6653	NULL
.	NULL

7	NULL
.	NULL

Conzelmann	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Corthésy	NULL
,	NULL
M.	NULL
Cianfriglia	NULL
,	NULL
A.	NULL
Silva	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1982	NULL
.	NULL

Hybrids	NULL
between	NULL
rat	NULL
lymphoma	NULL
and	NULL
mouse	NULL
T	NULL
cells	NULL
with	NULL
inducible	NULL
cytolytic	NULL
activity	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
298	NULL
:	NULL
170-172	NULL
.	NULL

8	NULL
.	NULL

Dailey	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
C.	NULL
Basilico	NULL
.	NULL

1985	NULL
.	NULL

Sequences	NULL
in	NULL
the	NULL
polyomavirus	NULL
DNA	NULL
regulatory	NULL
region	NULL
involved	NULL
in	NULL
viral	NULL
DNA	NULL
replication	NULL
and	NULL
early	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

54:739-749	NULL
.	NULL

9	NULL
.	NULL

Dexter	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
J.	NULL
Garland	NULL
,	NULL
D.	NULL
Scott	NULL
,	NULL
E.	NULL
Scolnick	NULL
,	NULL
and	NULL
D.	NULL
Metcalf	NULL
.	NULL

1980	NULL
.	NULL

Growth	NULL
of	NULL
factor-dependent	NULL
hemopoietic	NULL
precursor	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

152:1036-1047	NULL
.	NULL

10	NULL
.	NULL

Espel	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
Fromental	NULL
,	NULL
P.	NULL
Reichenbach	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1990	NULL
.	NULL

Activity	NULL
and	NULL
interleukin	NULL
1	NULL
responsiveness	NULL
of	NULL
SV40	NULL
enhancer	NULL
motifs	NULL
in	NULL
a	NULL
rodent	NULL
immature	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:929-937	NULL
.	NULL

10a.Flores	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

Personal	NULL
communication	NULL
.	NULL

11	NULL
.	NULL

Geering	NULL
,	NULL
G.	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

Old	NULL
,	NULL
and	NULL
E.	NULL
Boyse	NULL
.	NULL

1966	NULL
.	NULL

Antigens	NULL
of	NULL
leukemias	NULL
induced	NULL
by	NULL
naturally	NULL
occurring	NULL
murine	NULL
leukemia	NULL
virus	NULL
:	NULL
their	NULL
relation	NULL
to	NULL
the	NULL
antigens	NULL
of	NULL
gross	NULL
virus	NULL
and	NULL
other	NULL
murine	NULL
leukemia	NULL
viruses	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

124:753-772	NULL
.	NULL

12	NULL
.	NULL

Geiger	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Andus	NULL
,	NULL
J.	NULL
Klapproth	NULL
,	NULL
H.	NULL
Northoff	NULL
,	NULL
and	NULL
P.	NULL
C.	NULL
Heinrich	NULL
.	NULL

1988	NULL
.	NULL

Induction	NULL
of	NULL
«	NULL
l-acid	NULL
glycoprotein	NULL
by	NULL
recombinant	NULL
human	NULL
interleukin-1	NULL
in	NULL
rat	NULL
hepatoma	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:7141-7146	NULL
.	NULL

13	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homology	NULL
to	NULL
re	NULL
?	NULL

and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
K.	NULL
J.	NULL
Kim	NULL
,	NULL
I	NULL
.	NULL

Green	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1982	NULL
.	NULL

Ia	NULL
antigen-bearing	NULL
B	NULL
cell	NULL
tumor	NULL
lines	NULL
can	NULL
present	NULL
protein	NULL
antigen	NULL
and	NULL
alloantigen	NULL
in	NULL
a	NULL
major	NULL
histocompatibility	NULL
complex-restricted	NULL
fashion	NULL
to	NULL
antigen-reactive	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

155:445-459	NULL
.	NULL

Imagawa	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
,	NULL
1987	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-2	NULL
mediates	NULL
induction	NULL
by	NULL
two	NULL
different	NULL
signal-transduction	NULL
pathways	NULL
:	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
cAMP	NULL
.	NULL

Cell	NULL
51:251-260	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
W.	NULL
H.	NULL
Landschulz	NULL
,	NULL
B.	NULL
J.	NULL
Graves	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
rat	NULL
liver	NULL
nuclear	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
enhancer	NULL
core	NULL
element	NULL
of	NULL
three	NULL
animal	NULL
viruses	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:133-146	NULL
.	NULL

Julius	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
E.	NULL
Simpson	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1973	NULL
.	NULL

A	NULL
rapid	NULL
method	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
functional	NULL
thymus-derived	NULL
murine	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

3:645-649	NULL
.	NULL

Kanno	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Fromental	NULL
,	NULL
A.	NULL
Staub	NULL
,	NULL
F.	NULL
Ruffenach	NULL
,	NULL
I.	NULL
Davidson	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
SV40	NULL
TC-II	NULL
(	NULL
«	NULL
B	NULL
)	NULL
and	NULL
the	NULL
related	NULL
H-2K	NULL
``	NULL
enhansons	NULL
exhibit	NULL
different	NULL
cell	NULL
type	NULL
specific	NULL
and	NULL
inducible	NULL
protoenhancer	NULL
activities	NULL
,	NULL
but	NULL
the	NULL
SV40	NULL
core	NULL
sequence	NULL
and	NULL
the	NULL
AP-2	NULL
binding	NULL
site	NULL
have	NULL
no	NULL
enhanson	NULL
properties	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:4205-4214	NULL
.	NULL

Kaplan	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
C.	NULL
Shope	NULL
,	NULL
and	NULL
W.	NULL
D.	NULL
Peterson	NULL
,	NULL
Jr.	NULL
1974	NULL
.	NULL

Epstein-barr	NULL
virus-negative	NULL
human	NULL
malignant	NULL
T-cell	NULL
lines	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

139:1070-1076	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerchhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-KB	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
re/	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kimura	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
and	NULL
P.	NULL
Kouriisky	NULL
.	NULL

1986	NULL
.	NULL

Detailed	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
H-2K	NULL
``	NULL
promoter	NULL
:	NULL
enhancer-like	NULL
sequences	NULL
and	NULL
their	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
class	NULL
I	NULL
gene	NULL
expression	NULL
.	NULL

Cell	NULL
44:261-272	NULL
.	NULL

Lanzavecchia	NULL
,	NULL
A	NULL
.	NULL

1985	NULL
.	NULL

Antigen-specific	NULL
interaction	NULL
between	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
314:537-540	NULL
.	NULL

Lawrence	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

A.	NULL
Reilly	NULL
.	NULL

1990	NULL
.	NULL

An	NULL
expectation	NULL
maximization	NULL
(	NULL
EM	NULL
)	NULL
algorithm	NULL
for	NULL
the	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
common	NULL
sites	NULL
in	NULL
unaligned	NULL
biopolymer	NULL
sequences	NULL
.	NULL

Proteins	NULL
Struct	NULL
.	NULL

Funct	NULL
.	NULL

Genet	NULL
.	NULL

7:41-51	NULL
.	NULL

Lo	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
R.	NULL
Landau	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Smale	NULL
.	NULL

1991	NULL
.	NULL

LyF-l	NULL
,	NULL
a	NULL
transcriptional	NULL
regulator	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
novel	NULL
class	NULL
of	NULL
promoters	NULL
for	NULL
lymphocyte-specific	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
:	NULL
5229-5243.	NULL
.	NULL

Macchi	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
M.	NULL
Bornert	NULL
,	NULL
I.	NULL
Davidson	NULL
,	NULL
M.	NULL
Kanno	NULL
,	NULL
R.	NULL
Rosales	NULL
,	NULL
M.	NULL
Vigneron	NULL
,	NULL
J.	NULL
H.	NULL
Xiao	NULL
,	NULL
C.	NULL
Fromental	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
SV40	NULL
TC-II	NULL
(	NULL
«	NULL
B	NULL
)	NULL
enhanson	NULL
binds	NULL
ubiquitous	NULL
and	NULL
cell	NULL
type	NULL
specifically	NULL
inducible	NULL
nuclear	NULL
proteins	NULL
from	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:4215-4227	NULL
.	NULL

Minowada	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Tsubota	NULL
,	NULL
M.	NULL
F.	NULL
Greaves	NULL
,	NULL
and	NULL
T.	NULL
R.	NULL
Walters	NULL
.	NULL

1977	NULL
.	NULL

A	NULL
non-T	NULL
,	NULL
non-B	NULL
human	NULL
leukemia	NULL
cell	NULL
line	NULL
(	NULL
NALM-1	NULL
)	NULL
:	NULL
establishment	NULL
of	NULL
the	NULL
cell	NULL
line	NULL
and	NULL
preserice	NULL
of	NULL
leukemia-associ-ated	NULL
antigens	NULL
.	NULL

J.	NULL
Nati	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

59:83-87	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
C.	NULL
Wang	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
transcription	NULL
in	NULL
vitro	NULL
:	NULL
enhancer-binding	NULL
protein	NULL
AP-2	NULL
is	NULL
inhibited	NULL
by	NULL
SV40	NULL
T	NULL
antigen	NULL
.	NULL

Cell	NULL
50:847-861.	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differen-tially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:10028-10032	NULL
.	NULL

Nabholz	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Cianfriglia	NULL
,	NULL
O.	NULL
Acuto	NULL
,	NULL
A.	NULL
Conzelmann	NULL
,	NULL
A.	NULL
Weiss	NULL
,	NULL
W.	NULL
Haas	NULL
,	NULL
and	NULL
H.	NULL
von	NULL
Boehmer	NULL
.	NULL

1981	NULL
.	NULL

The	NULL
production	NULL
of	NULL
murine	NULL
cytolytic	NULL
T-cell	NULL
hybrids	NULL
,	NULL
p.	NULL
539-547	NULL
.	NULL

In	NULL
G.	NULL
J.	NULL
Himmerling	NULL
,	NULL
U.	NULL
Himmerling	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Kearney	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Monoclonal	NULL
antibodies	NULL
and	NULL
T-cell	NULL
hybridomas	NULL
:	NULL
perspectives	NULL
and	NULL
technical	NULL
advances	NULL
.	NULL

Elsevier/North	NULL
Holland	NULL
Biomedical	NULL
Press	NULL
,	NULL
Amster-dam	NULL
.	NULL

Nagata	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Tsuchiya	NULL
,	NULL
S.	NULL
Asano	NULL
,	NULL
O.	NULL
Yamamoto	NULL
,	NULL
Y.	NULL
Hirata	NULL
,	NULL
N.	NULL
Kubota	NULL
,	NULL
M.	NULL
Oheda	NULL
,	NULL
H.	NULL
Nomura	NULL
,	NULL
and	NULL
T.	NULL
Yamazaki	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
chromosomal	NULL
gene	NULL
structure	NULL
and	NULL
two	NULL
mRNAs	NULL
for	NULL
human	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:575-581	NULL
.	NULL

Nicolas	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
D.	NULL
Wegmann	NULL
,	NULL
P.	NULL
Lebrun	NULL
,	NULL
D.	NULL
Kaiserlian	NULL
,	NULL
J.	NULL
Tovey	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
Glasebrook	NULL
.	NULL

1987	NULL
.	NULL

Relationship	NULL
of	NULL
B	NULL
cell	NULL
Fc	NULL
receptors	NULL
to	NULL
T	NULL
cell	NULL
recognition	NULL
of	NULL
M1s	NULL
antigen	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

17:1561-1565	NULL
.	NULL

Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
and	NULL
P.	NULL
Tempst	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IxB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodefi-ciency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Picard	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
lymphocyte-specific	NULL
enhancer	NULL
in	NULL
the	NULL
mouse	NULL
immunoglobulin	NULL
k	NULL
gene	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
307:80-82	NULL
.	NULL

Poli	NULL
,	NULL
V.	NULL
,	NULL
F.	NULL
P.	NULL
Mancini	NULL
,	NULL
and	NULL
R.	NULL
Cortese	NULL
.	NULL

1990	NULL
.	NULL

IL-6DBP	NULL
,	NULL
a	NULL
nuclear	NULL
protein	NULL
involved	NULL
in	NULL
interleukin-6	NULL
signal	NULL
transduction	NULL
,	NULL
defines	NULL
a	NULL
new	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
related	NULL
to	NULL
C/EBP	NULL
.	NULL

Cell	NULL
63:643-653	NULL
.	NULL

Romero	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Eberl	NULL
,	NULL
J.	NULL
L.	NULL
Casanova	NULL
,	NULL
A.	NULL
S.	NULL
Cordey	NULL
,	NULL
C.	NULL
Widmann	NULL
,	NULL
I.	NULL
F.	NULL
Luescher	NULL
,	NULL
G.	NULL
Corradin	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Maryanski	NULL
.	NULL

1992	NULL
.	NULL

Immunization	NULL
with	NULL
synthetic	NULL
peptides	NULL
containing	NULL
a	NULL
defined	NULL
malaria	NULL
epitope	NULL
induces	NULL
a	NULL
highly	NULL
diverse	NULL
CTL	NULL
response	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1871-1878	NULL
.	NULL

Ron	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
R.	NULL
Brasier	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Habener	NULL
.	NULL

1991	NULL
.	NULL

Angiotensinogen	NULL
gene-inducible	NULL
enhancer-binding	NULL
protein	NULL
1	NULL
,	NULL
a	NULL
member	NULL
of	NULL
a	NULL
new	NULL
family	NULL
of	NULL
large	NULL
nuclear	NULL
proteins	NULL
that	NULL
recognize	NULL
nuclear	NULL
factor	NULL
xB-binding	NULL
sites	NULL
through	NULL
a	NULL
zinc	NULL
finger	NULL
motif	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2887-2895	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.	NULL
H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Schmid	NULL
,	NULL
W.	NULL
,	NULL
U.	NULL
Strahle	NULL
,	NULL
G.	NULL
Schiitz	NULL
,	NULL
J.	NULL
Schmitt	NULL
,	NULL
and	NULL
H.	NULL
Stunnen-berg	NULL
.	NULL

1989	NULL
.	NULL

Glucocorticoid	NULL
receptor	NULL
binds	NULL
cooperatively	NULL
to	NULL
adjacent	NULL
recognition	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

§:2257-2263.	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Miller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
,	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
M.	NULL
A.	NULL
Collart	NULL
,	NULL
P.	NULL
Vassalli	NULL
,	NULL
S.	NULL
A.	NULL
Nedospasov	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Jongeneel	NULL
.	NULL

1990	NULL
.	NULL

«	NULL
B-type	NULL
enhancers	NULL
are	NULL
involved	NULL
in	NULL
lipopolysaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
in	NULL
primary	NULL
macrophages	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:35-47	NULL
.	NULL

Shimizu	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Mitomo	NULL
,	NULL
T.	NULL
Watanabe	NULL
,	NULL
S.	NULL
Okamoto	NULL
,	NULL
and	NULL
K.-I	NULL
.	NULL

Yamamoto	NULL
.	NULL

1990	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
B-like	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
interleukin-6	NULL
gene	NULL
by	NULL
inflammatory	NULL
lymphokines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:561-568	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

S1	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

TRANSCRIPTION	NULL
FACTOR	NULL
NP-TC	NULL
,	NULL
5227	NULL
Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Chedid	NULL
,	NULL
J.	NULL
Suttles	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Pollok	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Mizel	NULL
.	NULL

1989	NULL
.	NULL

Interleukin	NULL
1	NULL
and	NULL
cyclic	NULL
AMP	NULL
induce	NULL
k	NULL
immunoglobulin	NULL
light-chain	NULL
expression	NULL
via	NULL
activation	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
DNA-binding	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:959-964.	NULL
.	NULL

Silva	NULL
,	NULL
A.	NULL
,	NULL
H.	NULL
R.	NULL
MacDonald	NULL
,	NULL
A.	NULL
Conzelmann	NULL
,	NULL
P.	NULL
Corthésy	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1983	NULL
.	NULL

Rat	NULL
x	NULL
mouse	NULL
T-cell	NULL
hybrids	NULL
with	NULL
inducible	NULL
specific	NULL
cytolytic	NULL
activity	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

76:105-129	NULL
.	NULL

Simek	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
R.	NULL
M.	NULL
Stephens	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1986	NULL
.	NULL

Localization	NULL
of	NULL
the	NULL
v-re	NULL
!	NULL

protein	NULL
in	NULL
reticuloendotheliosis	NULL
virus	NULL
strain	NULL
T-trans-formed	NULL
lymphoid	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

59:120-126	NULL
.	NULL

Sperisen	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
M.	NULL
Wang	NULL
,	NULL
P.	NULL
Reichenbach	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
PCR	NULL
based	NULL
assay	NULL
for	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

PCR	NULL
Methods	NULL
Appl	NULL
.	NULL

1:164-170	NULL
.	NULL

Sterneck	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
Muller	NULL
,	NULL
S.	NULL
Katz	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1992	NULL
.	NULL

Autocrine	NULL
growth	NULL
induced	NULL
by	NULL
kinase	NULL
type	NULL
oncogenes	NULL
in	NULL
myeloid	NULL
cells	NULL
requires	NULL
SP-1	NULL
and	NULL
NF-M	NULL
,	NULL
a	NULL
myeloid	NULL
specific	NULL
C/EBP	NULL
-like	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:115-126	NULL
.	NULL

Stormo	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hartzell	NULL
III	NULL
.	NULL

1989	NULL
.	NULL

Identifying	NULL
protein-binding	NULL
sites	NULL
from	NULL
unaligned	NULL
DNA	NULL
fragments	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1183-1187	NULL
.	NULL

Tooze	NULL
,	NULL
J	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

.	NULL

1982	NULL
.	NULL

DNA	NULL
tumor	NULL
viruses	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Tyrrell	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
Pidoux	NULL
.	NULL

1986	NULL
.	NULL

Quantitative	NULL
differences	NULL
in	NULL
host	NULL
cell	NULL
reactivation	NULL
of	NULL
ultraviolet-damaged	NULL
virus	NULL
in	NULL
human	NULL
skin	NULL
fibroblasts	NULL
and	NULL
epidermal	NULL
keratinocytes	NULL
cultured	NULL
from	NULL
the	NULL
same	NULL
foreskin	NULL
biopsy	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

46:2665-2669.	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Hengartner	NULL
,	NULL
M.	NULL
Nabholz	NULL
,	NULL
W.	NULL
Lernhardt	NULL
,	NULL
M.	NULL
H.	NULL
Schreier	NULL
,	NULL
and	NULL
W.	NULL
Haas	NULL
.	NULL

1979	NULL
.	NULL

Fine	NULL
specificity	NULL
of	NULL
a	NULL
continuously	NULL
growing	NULL
killer	NULL
cell	NULL
clone	NULL
specific	NULL
for	NULL
H-Y	NULL
antigen	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

9:592-597	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
W.	NULL
H.	NULL
Fischer	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
thymus-specific	NULL
member	NULL
of	NULL
the	NULL
HMG	NULL
protein	NULL
family	NULL
regulates	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
Ca	NULL
enhancer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:656-669	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1990	NULL
.	NULL

Purification	NULL
of	NULL
TCF-la	NULL
«	NULL
,	NULL
a	NULL
T-cell-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
the	NULL
T-cell	NULL
receptor	NULL
Ca	NULL
gene	NULL
enhancer	NULL
in	NULL
a	NULL
context-dependent	NULL
man-ner	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2:621-636	NULL
.	NULL

Yano	NULL
,	NULL
O.	NULL
,	NULL
J.	NULL
Kanellopoulos	NULL
,	NULL
M.	NULL
Kieran	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
and	NULL
P.	NULL
Kourilsky	NULL
.	NULL

1987	NULL
.	NULL

Purification	NULL
of	NULL
KBF1	NULL
,	NULL
a	NULL
common	NULL
factor	NULL
binding	NULL
to	NULL
both	NULL
H-2	NULL
and	NULL
B2-microglobulin	NULL
enhancers	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:3317-3324	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeverle	NULL
.	NULL

1990	NULL
.	NULL

Purified	NULL
human	NULL
IxB	NULL
can	NULL
rapidly	NULL
dissociate	NULL
the	NULL
complex	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
with	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

Cell	NULL
61:255-265	NULL
.	NULL

